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Abstract 
Formation of a complex multiple-chambered heart from the simple linear heart tube does 
not only require orchestrated morphogenesis of the myocardium, but also cardiac muscle 
differentiation and changes in intercellular electrical coupling. To date, the processes that 
lead to the formation of a functional syncytium are incompletely understood. One of the 
major pathways controlling multiple aspects of organogenesis and tissue morphogenesis is 
the planar cell polarity (PCP) pathway. Changes in tissue architecture are controlled by cell 
intercalation and collective cell migration. It is widely accepted that Wnt/PCP signaling plays 
a crucial role in guiding these cellular processes. This study provides evidence that 
morphogenesis of the heart is controlled by the non-canonical ligands Wnt11 and Wnt5b 
and the PCP core components Fzd7, Vangl2, Dvl2, and Pk1 through regulation of cell 
rearrangements during embryonic cardiac remodeling. Downstream effectors of the PCP 
pathway target adhesion processes, cytoskeleton, and migration. Here, it is revealed that 
PCP signaling in the heart affects cardiomyocyte morphology and actomyosin organization. 
Specifically, changes in the subcellular localization of the phosphorylated non-muscle 
myosin II regulatory light chain (pMRLC) at LHT stage are targeted by the PCP pathway 
core components. Furthermore, actomyosin relocalization concurs with changes in nuclear 
tension and SRF signal transduction within the myocardium. This study unravels a novel 
function of the PCP core component Pk1 in regulation of SRF translocation and target gene 
expression that is critical to cardiac maturation. Taken together, this study provides 
evidence that the PCP pathway is a major regulator of cardiac remodeling and organ 
maturation by modulating mechanosensitive SRF signal transduction involved in muscle 
differentiation. 
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Zusammenfassung 
Im Zuge der frühen embryonalen Herzentwicklung entstehen ausgehend von einem 
einfachen Herzschlauch zwei deutlich voneinander getrennte Herzkammern. Die 
Kardiomyozyten des Atriums und Ventrikels weisen jeweils spezifische Eigenschaften auf, 
die sich morphologisch wie auch funktionell auf das Herz auswirken. Der Prozess dieser 
Spezifizierung ist jedoch bis dato nur partiell verstanden. Veränderungen in der 
Gewebsarchitektur werden hauptsächlich durch Zellinterkalation und kollektive 
Zellmigration erreicht. Viele Studien zeigen, dass der Wnt/PCP-Signalweg eine essentielle 
Rolle in der Regulation dieser Bewegungen einnimmt. Die Daten dieser Studie belegen, 
dass die nicht-kanonischen Liganden Wnt11 und Wnt5b sowie die Kernkomponenten des 
PCP Signalweges Fzd7, Vangl2, Dvl2 und Pk1 an der Steuerung der Reorganisation der 
Kardiomyozyten während der Kammerbildung beteiligt sind, was Einfluss auf die Architektur 
des frühen Myokardiums nimmt. Effektoren des PCP Signalweges umfassen das 
Zytoskelett sowie Adhäsions- und Migrationsprozesse. In dieser Studie wird gezeigt, dass 
die Komponenten dieses Signalweges im Myokardium hauptsächlich Prozesse der 
Actomyosin Modulation regulieren und damit unter anderem die Morphologie der 
Kardiomyozyten beeinflussen. Zusätzlich ist die frühe Kardiogenese durch eine 
Relokalisierung der phosphorylierten Form der Myosin Regulatory Light Chain (MRLC) vom 
Kern zur Membran gekennzeichnet. Hier wird gezeigt, dass die Phosphorylierung von 
MRLC sowie die Relokalisation von den Kernkomponenten des PCP Signalweges 
kontrolliert werden. Die vorliegende Studie legt weiterhin Indizien vor, dass es im Verlauf 
der frühen Herzentwicklung unter anderem durch die Relokalisierung von pMRLC zu 
Änderungen in der Gewebespannung kommt, welche sich auf die nukleäre Spannung 
auswirken und damit Veränderungen in der Genregulation hervorrufen. Diese 
Veränderungen werden hauptsächlich durch Effekte auf die Lokalisation und Aktivität des 
Serum Response Factors (SRF) vermittelt, welche in diesem Kontext durch die PCP 
Kernkomponente Pk1 reguliert sind. Zusammenfassend zeigen die hier vorgelegten 
Untersuchungen, dass der PCP Signalweg essentiell für die durch SRF gesteuerte 
Muskeldifferenzierung und die damit einhergehende Reifung des Herzens ist. 
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1 Introduction 
Congenital heart defects (CHD) refer to anomalies in the structure of the heart or great 
vessels that are present at birth. In Europe, CHD account for nearly one-third of newborns 
with major congenital anomalies diagnosed prenatally or in infancy (EUROCAT Access 
Prevalence Tables). Despite recent advances in prenatal diagnosis and treatment, CHD 
remain the leading cause of infant mortality with an average total prevalence of 0.8% of births 
in Europe (Dolk et al., 2011). Although there have been many advances in the understanding 
of CHD and several associated genes have been identified, the fundamental mechanisms 
involved in the emergence of these birth defects remain incompletely understood. Elucidating 
these mechanisms is therefore pivotal for improving treatment of both congenital and 
acquired heart disease. 
1.1 Early Cardiogenesis in Zebrafish 
Zebrafish are the ideal model organism to study early embryogenesis, because of their rapid 
external development, transparency of embryos and large amounts of offspring. In particular 
the fact that they develop for up to five days post fertilization (dpf) on diffused oxygen, allows 
studying the function of genes involved in cardiovascular development, which loss-of-
function usually causes lethality in other models (Burggren and Pinder, 1991; Chen and 
Fishman, 1996; Reiter et al., 1999; Yelon et al., 2000). 
Directly after fertilization, non-yolk cytoplasm streams towards the animal pole forming a 
single cell that is clearly separated from the granule-rich cytoplasm of the yolk. The following 
two to three hours post fertilization (hpf) are marked by cell divisions that lead to formation 
of the 128-cell Blastula stage. It is at this time that a membrane-enclosed group of nuclei on 
top of the yolk – the yolk syncytial layer (YSL) that serves as a boundary between yolk and 
blastoderm – is formed. After four hours of development, epiboly is initiated with the yolk 
bulging toward the animal pole and migration of blastomeres from the animal to the vegetal 
pole. After five hpf half of the yolk is covered by blastoderm (50%-epiboly) and a thickened 
marginal region – the germ ring – appears, marking the beginning of gastrulation. 
Convergence movements lead to local accumulation of cells at one position along the germ 
ring forming the embryonic shield. By the end of gastrulation, at around ten hpf the three 
primary germ layers – ectoderm, endoderm, and mesoderm – have been formed by 
involution that folds the blastoderm layer back upon itself, and the dorsoventral and 
anteroposterior body axis is established. Subsequently, segmentation is initiated by 
furrowing of the first somite at around 10.5 hpf (Kimmel et al., 2005). 
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Cardiac development is initiated by specification of myocardial and endocardial progenitor 
cells within the mesodermal germ layer at 5 hpf (Figure 1 A) (de Pater et al., 2009; Hami et 
al., 2011; Keegan, 2004). Before the start of gastrulation, two pools of myocardial progenitor 
cell types: atrial and ventricular precursors, are specified in two groups in the marginal zone 
at either side of the embryo with ventricular progenitors closer to the margin (Figure 1 B) 
(Buckingham et al., 2005; Stainier et al., 1993). At the same time endocardial progenitors 
locate to similar regions of the margin (Lee et al., 1994). During gastrulation and early somite 
stages, the cardiac progenitor cells migrate to the posterior half of the anterior lateral plate 
mesoderm (ALPM). The myocardial progenitors then migrate over the midline to form a disc-
shaped epithelium that fuses to develop the heart cone (Figure 1 C, D). Both, the endoderm 
and YSL were shown to control the migration of progenitors to the ventral midline (Glickman 
and Yelon, 2002; Kikuchi et al., 2000; Reiter et al., 1999; Sakaguchi, 2006). After the onset 
of somitogenesis, cardiac progenitors can be visualized by either their common expression 
of the transcription factor gene nkx2.5 and the cardiac myosin regulatory light chain gene 
myl7 or by atrial / ventricular precursor specific expression of ventricular myosin heavy chain 
(vmhc) or atrial myosin heavy chain (amhc/myh6) (Glickman and Yelon, 2002; Yelon et al., 
1999). During migration of myocardial precursors to the midline, endocardial progenitors 
proceed to coat the interior of the heart cone (Bussmann et al., 2007). At approximately 22 
hpf, further migration of both, endocardial and myocardial precursors, leads to formation of 
the linear heart tube (LHT) a transient structure composed of an inner endothelial tube 
surrounded by an immature myocardial single-cell layer (Figure 1 E). 
At 24 hpf left-right asymmetry of the developing heart is achieved through laterality cues that 
initiate cardiac jogging and looping. First, leftward jogging displaces the LHT relative to the 
dorsal midline (Figure 1 F). Subsequent cardiac looping creates distinct asymmetry of the 
heart at 36 hpf (Figure 1 G) (Ahmad, 2004). Ciliary function within the laterality organ known 
as Kuppfer’s vesicle has been shown to be crucial for the direction of cardiac jogging and 
looping (Ferrante et al., 2008; Spéder et al., 2007).  
The vertebrate heart is specified and formed by two heart fields: first heart field (FHF) and 
second heart field (SHF). In mouse, cardiomyocytes of the FHF form the left ventricle (LV) 
and large portions of the atria, while the SHF builds most of the right ventricle (RV) and the 
outflow tract (OFT) (Buckingham et al., 2005; Hamblet, 2002; Henderson et al., 2006). In 
zebrafish, the LHT is formed by the FHF cardiomyocytes (Mosimann et al., 2015). As 
cardiogenesis proceeds, cardiomyocytes of the SHF are added to the arterial and venous 
pole of the heart tube (de Pater et al., 2009; Gessert and Kühl, 2010; Hami et al., 2011; 
Mosimann et al., 2015; Rohr et al., 2008; Zhou et al., 2011).  
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Figure 1: Early cardiac development in zebrafish.  (A) Cardiac progenitor cells are specified within the 
mesodermal germ layer. (B) Atrial and ventricular precursors are specified in two groups in the marginal zone of 
the pharyngeal mesoderm. (C) Endocardial progenitors lie anterior in the anterior lateral plate mesoderm (ALPM). 
Precursors migrate to the ventral midline and (D) bilateral heart fields fuse to form a heart cone with endocardial 
cells in the center. (E) Formation of the primitive linear heart tube (LHT) with the endocardium as an inner lining. 
The venous pole of the LHT is located at the anterior left and the arterial pole stays fixed at the midline. (F) 
Cardiac looping establishes left-right asymmetry and (G) AV canal formation separates atrium from ventricle while 
the heart assumes a characteristic S-formed shape. (H, I) Transversal view of chambered heart. (H) Ventricular 
morphology establishes characteristic OC and IC regions (I) Ventricular trabeculation has started and the AV 
valve has formed. (A) lateral view, (B-F) dorsal view, (G) ventral view. IC = inner curvature, OC = outer curvature, 
hpf = hours post fertilization, AV = atrioventricular. (modified from: Bakkers, 2011; Staudt & Stainier, 2012). 
 
The accrual of SHF and bulging of cardiomyocytes off the heart tube contributes to the 
formation and the expansion of the cardiac chambers (Figure 1 G, H) (Christoffels et al., 
2000). In zebrafish ventricle, cardiomyocytes of the SHF are incorporated mainly to the inner 
curvature (IC), while the outer curvature (OC) mostly consists of cells of the FHF (de Pater 
et al., 2009; Mosimann et al., 2015). After cardiac looping and formation of the two-
chambered heart clear differences in size and shape between OC and IC cardiomyocytes 
emerge (Figure 1 H) (Auman et al., 2007).  
At LHT stage and during cardiac looping only two cellular layers form the primitive heart: the 
endocardium surrounded by the myocardium. At 48 hpf another extracardiac layer, the pro-
epicardium, can be distinguished close to the ventral wall of the looped heart  
(Figure 1 H). The pro-epicardium consists of a group of spherical cells that attach to the 
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myocardium and start to spread over the myocardial surface to form the epicardium at  
72 hpf (Figure 1 I) (Liu and Stainier, 2010; Peralta et al., 2013; Serluca, 2008). 
In the course of cardiac looping two pronounced areas of constriction appear: the 
atrioventricular (AV) canal between atrium and ventricle, and the OFT between ventricle and 
great arteries (Hinton and Yutzey, 2011; Hu et al., 2000). Subsequently, cardiac cushion 
tissue in these regions is formed predominantly by endocardial epithelial-mesenchymal 
transition (EMT) (Markwald et al., 1977; Markwald et al., 1975). The AV and OFT cushion 
tissues ensure further development of valve primordia to maintain unidirectional blood flow. 
Here, the cushion tissue of the OFT gives rise to semilunar valve, whereas AV valve 
originates from that of the AV region (Figure 1 I) (Person et al., 2005). While cardiac growth 
at LHT stage is mainly achieved through addition of SHF cardiomyocytes, proliferation within 
the myocardium increases progressively after 48 hpf (Liu et al., 2010). Around 72 hpf at the 
end of cardiac looping cardiac trabeculation is initiated. This process describes the formation 
of a meshwork of highly organized sheet-like muscular structures within the ventricular 
cavities (Ben-Shachar et al., 1985). These trabeculae form through extrusion and expansion 
of differentiated cardiomyocytes and therefore consist of myocardial cells that are mantled 
by the endocardial layer. The purpose of these trabeculae is to increase cardiac output and 
maximize nutrition and oxygen uptake in the embryonic myocardium before the development 
of coronary arteries (Liu et al., 2010; Rychter and Ostádal, 1971; Sedmera et al., 1997). For 
subsequent cardiac chamber maturation, remodeling of trabeculae is essential and requires 
myocardial proliferation, development of the coronary vasculature and maturation of the 
conduction system (Weiford et al., 2004). At around 120 hpf the AV valves are fully formed 
preventing retrograde flow between the chambers and the epicardium covers the entire 
surface of the myocardium (Figure 1 I). 
During embryonic development, the heart is the first organ to form and function. Thus, 
cardiogenesis comprises not only morphological, but also functional changes within the 
myocardium. Importantly, the heart maintains its physiologic pumping function during 
remodeling from LHT stage to its chambered form. This requires synchronization of cardiac 
remodeling and electrical coupling between cardiomyocytes. Blood flow, established as the 
blood is pumped from the venous to the arterial pole, is crucial to ensuing cardiogenesis, 
together with other embryogenic processes that respond to hemodynamic signals (Dietrich 
et al., 2014; Moorman, 2003; North et al., 2009; Reckova, 2003). Although still controversial, 
at the early stages the linear hear tube contracts either as a peristaltic or as an impedance 
pump (Forouhar, 2006; Männer et al., 2010). Cardiomyocytes of the linear heart tube are 
characterized by its slow proliferation rate, slow conduction velocity, and poor contractility 
(Panáková et al., 2010; Rana et al., 2013; Soufan et al., 2006). As the formation of the two 
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cardiac chambers proceeds, cardiomyocytes of the OFT, IC, AV canal, and sinus venosus 
(SV) preserve this primary phenotype and give rise to the, zones of slow conduction 
(Christoffels et al., 2010; Mosimann et al., 2015; Panáková et al., 2010). Whereas atrial and 
ventricular cardiomyocytes acquire different characteristics that are associated with fast 
conduction velocity and increased contractility (Christoffels et al., 2010). 
1.1.1 Gene Regulatory Networks in Cardiac Development 
During early heart development cardiomyocyte differentiation is controlled by interactions 
between various cardiac-restricted evolutionary conserved transcription factors that direct 
cardiac cell fates, myocyte differentiation, and cardiac morphogenesis (Moorman, 2003; 
Olson, 2006; Staudt and Stainier, 2012). 
Specification of cardiac precursors is regulated by a variety of signaling pathways, including 
retinoic acid (RA) (Keegan, 2005), Wnt (Ueno et al., 2007), Hedgehog (Hh) (Voss et al., 
2009), fibroblast growth factor (Fgf) (Marques et al., 2008), bone morphogenic protein (Bmp) 
(Dietrich et al., 2014; Marques and Yelon, 2009; North et al., 2009; Reckova, 2003; Reiter et 
al., 2001), and Nodal (Keegan, 2004; Reiter et al., 2001; Stainier et al., 1993). Induction of 
heart lineages requires inhibition of Wnt signaling in lateral margins of the head precursor 
zone, where BMP signaling is maintained (Marvin, 2001). Here, both BMPs, Wnts and Wnt 
antagonists likely act in a concentration-dependent manner to ensure cardiac cell 
specification (Alsan and Schultheiss, 2002; Schneider, 2001). However, how the multitude 
of pathways interacts with each other to control the cell fate of myocardial progenitors 
remains mostly elusive. 
The first wave of cardiac progenitor migration from mesendodermal structures is governed 
by Fgf8 and the basic helix-loop-helix transcription factors Mesoderm posterior 1 and 2 
(Mesp 1 and 2) (Kitajima et al., 2000; Sun et al., 1999). Subsequent cardiac gene expression 
is regulated by a kernel of transcription factors that is expressed in cardiomyocytes and 
indispensable for initiation and maintenance of cardiac gene expression: NK2 transcription 
factor related, locus 2 (Nkx2.5), GATA-binding protein 4 (Gata4), T-box 5 and 20 (Tbx5 and 
Tbx20), heart and neural crest derivatives expressed transcript 1 or 2 (Hand1/Hand2), the 
MADS domain TF serum response factor (SRF) and myocyte-enhancer factor 2A (Mef2a) 
(Cripps and Olson, 2002; Harvey et al., 2002; He et al., 2011). Notably, not only Gata4, but 
also other members of the GATA transcription factor family - Gata5 and Gata6 - control 
several aspects of heart formation from specification to migration (Holtzinger and Evans, 
2007; Hu et al., 2000; Peterkin et al., 2007). Another transcription factor, Myocardin, was 
shown to be co-expressed with Nkx2.5. Myocardin belongs to a family of chromatin-
remodeling proteins and forms a ternary complex with SRF. Binding of Myocardin to SRF 
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binding sites was shown to result in efficacious activation of cardiac gene expression (Wang 
et al., 2001). 
The transcription factor Hand2 functions to increase the amount of ventricular progenitors 
and is necessary for the maintenance of the expression of tbx5 (T-box transcription factor 5), 
that has been shown to be crucial for heart development (Garrity et al., 2002; Le A Trinh et 
al., 2005). Further migration of cardiac progenitor cells to the ALPM requires nkx2.5, gata5, 
and hand2 activity as well as G-protein receptors (Chen and Fishman, 1996; Hsu et al., 1998; 
Reiter et al., 1999; Scott et al., 2007; Yelon et al., 2000). Cardiac cell differentiation within 
the ALPM is controlled by neighboring vascular and hematopoietic precursors that affect 
hand2 expression and control atrial cell number (Schoenebeck et al., 2007). 
Jogging of the LHT and cardiac looping require cues of the left-right asymmetry signaling 
pathways that comprise the nodal-related gene southpaw (spaw) and its downstream effector 
pitx2, lefty1, and lefty2 (Ahmad, 2004). Pitx2 is furthermore crucial for the patterning of the 
aortic arches, the OFT, and the AV valves and cushions (Liu et al., 2002). Restricted 
expression of bmp4, versican and notch1b was observed within zones of constriction in the 
AV canal and OFT region (Beis, 2005; Timmerman et al., 2003; Walsh and Stainier, 2001). 
Several other signaling pathways were implicated in AV canal development, such as 
Calcineurin, Wnt, TGF-β, Prostaglandin and ErbB/Neureguling signaling cascades (Chang 
et al., 2004; Hurlstone et al., 2003; Scherz et al., 2008). 
The factors that control FHF and SHF specification are still poorly understood. However, 
Islet1 (Isl1), a LIM homeodomain transcription factor, has been described as a marker of the 
SHF, while Tbx5 marks progenitors of the FHF (Cai et al., 2003; Gessert and Kühl, 2009). 
Furthermore, it has been documented that proliferation and patterning of the SHF require 
Nkx2.5, Mef2c, Hand2, Pitx2, Foxh1 (Buckingham et al., 2005). Additionally, regulation of 
FGF ligand expression by Wnt/β-catenin and Notch signaling is crucial for proper SHF cell 
specification, while BMP and non-canonical Wnt signaling are essential for cardiomyocyte 
differentiation (Cohen et al., 2012; High et al., 2009; Hutson et al., 2010; Klaus et al., 2012; 
Park et al., 2008; Watanabe et al., 2010). 
Atrial and ventricular chamber formation is accompanied by morphological and functional 
changes within the myocardium. Several regulatory pathways regulate the processes that 
guide the development of the early single layered myocardium. A diverse set of transcription 
factors regulates cardiac chamber morphogenesis; most notably the T-box transcription 
factors Tbx2, Tbx3, Tbx5, and Tbx20, as well as Gata4, Nkx2.5, Nkx2.7, and Hand1. While 
Tbx5 and Tbx20 promote differentiation of atrial and ventricular cardiomyocytes by 
interaction with Nkx2.5 and Gata4, interaction of Tbx2 and Tbx3 with these transcription 
factors represses such specification. Here, both Nkx2.5 and Gata4 are highly expressed 
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throughout the primitive heart tube, whereas the different isoforms of T-box transcription 
factors show distinct expression patterns within the myocardium (Hoogaars et al., 2007). 
Furthermore, cardiac chamber size likely is regulated by both Nkx2.5 and Nkx2.7 (Targoff et 
al., 2013; Tu et al., 2009). 
1.2 Wnt Signaling in Cardiogenesis 
Wnt proteins are evolutionary conserved secreted cysteine-rich glycoproteins that regulate 
crucial aspects of embryonic development including proliferation, migration, cell-fate 
specification, adhesion and regeneration processes as well as ion homeostasis (De, 2011; 
Lim and Nusse, 2013; Willert and Nusse, 2012). Dysregulation of Wnt signaling is implicated 
in a variety of diseases such as cancer, bone malformations, obesity, diabetes, and 
neurodegenerative defects (Christodoulides, 2006; De Ferrari and Moon, 2006; Faienza et 
al., 2014; Giles et al., 2003; Grant et al., 2006; Nusse, 2005). The first member of the Wnt 
family, Wnt1, was discovered in mice during the 1980s as a proto-oncogene named int-1 
acting in oncovirus-induced breast cancer (Nusse and Varmus, 1982). Later it was revealed 
that int-1 is a sequence homologue to the gene wingless in Drosophila melanogaster that 
functions as a segment polarity gene and a combination of both gene names led to its 
description as Wnt (Nüsslein-Volhard and Wieschaus, 1980; Rijsewijk et al., 1987). To date, 
nineteen Wnt genes have been identified in mammals that fall into 12 conserved Wnt 
subfamilies. Here, different Wnt ligands activate either the canonical or the non-canonical 
cascade: (1) Canonical: Wnt1, Wnt2, Wnt3, Wnt8a, Wnt8b, Wnt10a, and Wnt10b, (2) Non-
canonical: Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7a, Wnt7b, and Wnt11), and (3) indeterminate 
groups: Wnt2b and Wnt9b (Wnt Website: www.stanford.edu/ 
~rnusse/wntwindow.html). 
The classical characterization of Wnt signaling distinguishes between the canonical and non-
canonical pathway. Briefly, the highly evolutionary conserved canonical Wnt transduction 
pathway acts through the stabilization of β-catenin regulating the expression of TCF/LEF 
target genes. In cells with little to no active Wnt signaling cytosolic β-Catenin is frequently N-
terminally phosphorylated, ubiquitinated and targeted for proteolysis by the E3-ubiquitin 
ligase in the so-called β-Catenin destruction complex comprising Axin, the Adenomatous 
polyposis coli (APC) protein and the Glycogen synthase kinase 3 (GSK3β) (Aberle et al., 
1997; Ikeda, 1998; Kitagawa et al., 1999).  
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Figure 2: Canonical Wnt / β-Catenin pathway activity is temporally regulated to ensure proper heart 
development. Mesoderm formation and proliferation of cardiomyocytes requires activation of canonical Wnt 
signaling. In contrast, specification of cardiac progenitors and terminal differentiation require attenuation of the 
canonical branch, while non-canonical Wnt signaling promotes these processes (modified from: Gessert & Kühl, 
2010). 
 
Activation of the Wnt signaling cascade leads to stabilization and accumulation of β-Catenin 
within the cytoplasm (Kimelman and Xu, 2006). Cytosolic β-Catenin translocates to the 
nucleus, where it regulates downstream gene expression by binding to Tcf/LEF family 
members (Behrens et al., 1996; Hsu et al., 1998; Keller et al., 1985). Tight temporal control 
of canonical Wnt/β-catenin signaling activity is absolutely crucial during early cardiogenesis 
where it is indispensable for early cardiac specification, but must be attenuated for the 
development of cardiomyocytes (Tzahor, 2007). Specifically, Wnt/β-catenin signaling acts 
upstream of processes that induce mesoderm formation and control Mesp1 activity that was 
described as the earliest marker of cardiovascular lineage (Behringer et al., 1999; Lindsley, 
2006; Saga, 2000). Later in development, however, canonical Wnt signal transduction is 
attenuated through Notch activity to allow cardiomyocyte differentiation, which additionally 
requires activation of the Wnt non-canonical pathway (Kwon et al., 2009; Pandur et al., 2002; 
Yamashita et al., 2005). Proliferation of cardiomyocytes is regulated by activation of Wnt/β-
Catenin signaling (Norden and Kispert, 2012; Norden et al., 2011). Finally, inhibition of 
Wnt/β-Catenin signaling is required to ensure terminal differentiation of cardiomyocytes 
(Naito et al., 2006; Qyang et al., 2007; Ueno et al., 2007; Zhu et al., 2008). At the same time, 
Wnt non-canonical signaling is activated to initiate terminal differentiation of cardiomyocyte 
(Figure 2) (Garriock et al., 2005; Gessert et al., 2008; Ueno et al., 2007). Several Wnt ligands 
are expressed during early cardiogenesis, including Wnt8, Wnt2a and b, Wnt5a and Wnt11 
(Cohen et al., 2008). 
Studies in Drosophila, Xenopus and zebrafish revealed β-Catenin-independent non-
canonical Wnt transduction pathways that comprise Wnt/Ca2+ signaling and the planar cell 
polarity (PCP) pathway (Figure 3) (Gessert and Kühl, 2010; Phillips, 2005; Yates et al., 
2010a; Yates et al., 2010b; Ybot-Gonzalez et al., 2007). In zebrafish, injection of Fzd2 and 
Wnt5a mRNA led to increased intracellular Ca2+ levels during gastrulation (Moon et al., 
1997). Heterotrimeric G-proteins activate Phosphoinositide-3-kinase (PI3K) and 
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Phospholipase C (PLC) leading to the synthesis of Inositol-1,4-5-triphosphate (IP3) and 
Diacylglycerol that triggers release of intracellular Ca2+ from the endoplasmic reticulum 
(Cantley, 2002; Moon et al., 1997; Sheldahl et al., 2003). Released Ca2+ ions activate the 
Protein kinase C (PKC), Calcineurin (CaCN) and the Ca2+/Calmodulin-dependent protein 
kinase II (CamKII) (Figure 3) (Kühl et al., 2000; Saneyoshi et al., 2002). Moreover, non-
canonical signaling mediated by Wnt11 was shown to attenuate transmembrane Ca2+ influx 
through down-regulation of L-type calcium channel (LTCC) conductance (Figure 3) 
(Panáková et al., 2010). 
The second classical branch of non-canonical Wnt signaling is the PCP pathway, which is 
the focus of this study and described in detail in the following section. 
1.2.1 Planar Cell Polarity Pathway 
PCP signaling refers to mechanisms responsible for the alignment of cells in a cooperative 
manner with a specific orientation that is orthogonal to the apicobasal axis within epithelial 
sheets. The non-canonical Wnt/PCP pathway was initially discovered in Drosophila 
melanogaster where it controls the alignment of actin hairs (trichomes) of the wing disc 
epithelium and the rotation of ommatidia in the eye (Adler et al., 1997; Gubb and García-
Bellido, 1982; Strutt et al., 1997; Wong and Adler, 1993). 
Although it is widely accepted that PCP needs to be established and maintained throughout 
the life-cycle of an organism, early studies in zebrafish and Xenopus mainly focused on its 
function in guiding convergent extension movements of mesenchymal cells during vertebrate 
gastrulation (Heisenberg et al., 2000; Tada and Smith, 2000; Wallingford et al., 2000). 
However, PCP signaling is indispensable for several morphogenetic processes also during 
organ development, in neural tube closure, ear patterning and hearing as well as lung and 
kidney branching (Phillips, 2005; Yates et al., 2010b; Yates et al., 2010a; Ybot-Gonzalez et 
al., 2007). Hence, it is not surprising that also proper cardiac development is dependent on 
planar cell polarity (PCP) signaling. It has been shown that defective regulation of the PCP 
pathway does generally result in CHD (Hamblet, 2002; Henderson et al., 2006; Marlow et 
al., 2002; Unterseher et al., 2004). Although the underlying mechanisms remain unresolved, 
it was shown that one of the major ligands of Wnt non-canonical signaling in the heart is 
Wnt11 that is crucial to normal heart development and cardiac gene expression. 
Furthermore, its overexpression was sufficient to induce contractile tissue formation (Afouda 
et al., 2008; Pandur et al., 2002). 
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Figure 3: Non-canonical Wnt signaling comprises the PCP pathway and Ca2+ signaling. Binding of non-
canonical Wnt ligands to the transmembrane receptor Fzd initiates PCP and/or Ca2+ signaling. The signal is 
relayed through the cytosolic protein Dvl that either (1) ensures Ca2+ release from the endoplasmic reticulum to 
activate the Calmodulin Kinase II (CamKII), the Protein kinase C (PKC), and Calcineurin (CaCN) that initiates 
NF-AT regulated gene expression or (2) forms a complex with Daam and RhoA to act on actomyosin and JNK to 
regulate effects on cell adhesion, planar polarity, and motility. (3) Wnt11 attenuation of LTCC function limits 
transmembrane Ca2+ influx. 
 
The PCP pathway core components Frizzled (Fzd), Van Gogh-like (Vangl), Dishevelled (Dvl), 
and Prickle (Pk) are transmembrane or membrane-associated proteins. Common for both 
canonical and non-canonical Wnt pathways is the initiation of signal transduction by binding 
of Wnt ligands to the seven-pass transmembrane receptor Fzd. The signal is then relayed 
through the cytosolic protein Dvl, which serves as a hub able to distinguish between signal 
transmission to either the canonical or to non-canonical branches of Wnt signaling. This is 
achieved through binding of interaction partners to its either N-terminal DIX (Dishevelled, 
Axin), central PDZ (Post-synaptic density 95, Discs-large, Zonula occludens-1) or C-terminal 
DEP domain (Dishevelled, Egl-10, Plekstrin) (Gao and Chen, 2010). The DIX domain is 
essential for the canonical Wnt pathway, the DEP domain mediates non-canonical PCP and 
Ca2+ signaling, while the PDZ domain is required for both non-canonical and canonical Wnt 
signaling (Axelrod et al., 1998; Boutros et al., 1998; Wallingford and Habas, 2005). 
Core components that are unique to Wnt/PCP signaling include the four-pass 
transmembrane protein Vangl, the cytoplasmic LIM- and PET-domain containing protein Pk, 
the atypical protocadherin Flamingo (Fmi), and the Ankyrin-repeat protein Diego (Dgo) (Chae 
et al., 1999; Feiguin et al., 2001; Gubb et al., 1999; Usui et al., 1999; Wolff and Rubin, 1998). 
Fzd, Dvl and Dgo are described as positive regulators of PCP signaling, while Pk and Vangl 
function as antagonists of the system (Ciruna et al., 2006). While Fmi can recruit either Fzd 
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or Vangl, both Dvl and Pk can be solely recruited by Vangl (Zallen, 2007). Furthermore, Dvl 
interacts competitively with either Pk or Dgo leading to either inhibition or activation of signal 
transduction (Jenny et al., 2005). In the Drosophila wing disc, PCP core components assume 
an asymmetric distribution with accumulation of Vangl and Pk at the proximal and Fzd, Dvl, 
and Dgo at the distal apical cortex of the membrane (Gray et al., 2011). Intercellular 
interaction of the core components establishes overall tissue polarity (Carvajal-Gonzalez et 
al., 2014). Finally, transmission of the signal to the effector proteins RhoA, Rac, and JNK 
results in changes of the cytoskeleton, planar polarity, cell adhesion, and cellular motility 
(Figure 3) (Marlow et al., 2002; Unterseher et al., 2004). Several studies show that the 
function of the PCP core components is highly dependent on proper expression of each of 
the aforementioned components (Keegan, 2004; Klein and Mlodzik, 2005; Krasnow et al., 
1995). 
1.3 PCP in Development and Disease 
Generally, genetic disruptions in PCP signaling cause severe developmental abnormalities 
like failure of neural tube closure or left/right patterning defects. Both the ligands and core-
components of Wnt non-canonical PCP signaling are crucial for various aspects of 
development from gastrulation movements to the morphogenesis of various organs. The 
necessity of tightly regulated non-canonical Wnt signaling during cardiogenesis was proven 
in several studies that implicate PCP signaling in the specification of cardiac progenitor cells, 
linear heart tube formation, cardiac looping and OFT development, and wound healing after 
myocardial infarction (MI) (Brade et al., 2006). A variety of Wnt ligands is upregulated in MI 
models and involved in subsequent development of hypertrophic phenotypes and cardiac 
wound healing (Aisagbonhi et al., 2011; Oerlemans et al., 2010). Furthermore, PCP signaling 
is pivotal to establishment of left-right asymmetry as both loss of Pk1a and Wnt11 leads to 
inverted heart looping (Oteiza et al., 2010). 
Notably, loss or overexpression of either core component of the PCP signaling pathway 
results in severe cardiomyopathies. Cardiac-specific Dvl upregulation in mice results in 
myocardial hypertrophy (Malekar et al., 2010). Looptail (Lp) mutant mice, which carry a 
missense mutation in Vangl2, display neural tube defects like spina bifida or 
craniorachischisis as well as heart looping defects during early cardiogenesis and the outflow 
tract abnormality double-outlet right ventricle (DORV) (Henderson et al., 2001; McGreevy et 
al., 2015). In humans, homozygous mutations in Pk1 result in progressive myoclonus 
epilepsy that is characterized by general neurological decline resulting in seizures, ataxia, 
and dementia and in neural tube closure defects (Bassuk et al., 2008; Bosoi et al., 2011). 
Furthermore, it was shown in mice that Pk1 is highly expressed in developing digit rays and 
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required for limb growth (Yang et al., 2013). In zebrafish, overexpression of a dominant-
negative mutant of Dvl2 missing the DEP domain induced cardiac bifida phenotypes (Matsui, 
2005). 
Although dysregulation of Wnt signaling cascades mainly results in heart defects, few studies 
show beneficial outcomes after suppression of the Wnt signaling cascade. Here, expression 
of secreted frizzled related proteins (SFRPs) that compete for Wnt binding to Fzd was shown 
to have positive effects on cardiac remodeling after injury (He et al., 2010; Mirotsou et al., 
2007). 
1.4 Tissue Morphogenesis During Organogenesis 
Morphogenesis refers to the processes during embryonic development where tissues 
undergo bending, narrowing, lengthening, branching, and folding to acquire distinct shapes 
necessary to form functional organs. During morphogenesis, proper organ shape is acquired 
by tight regulation of the interplay between changes in cell shape, cell organization, and 
mechanical forces that affect the tissue architecture (Papusheva and Heisenberg, 2010).  
1.4.1 Collective Cell Behaviors 
Firstly, the importance of changes in cell shape and organization was studied extensively for 
convergent extension (CE) movements during Xenopus gastrulation. Here, convergence 
movements narrow embryonic tissues over the mediolateral axis, whereas extension 
movements elongate them along the perpendicular axis from head to tail (Wallingford et al., 
2002). These movements are mostly guided by mediolateral intercalation and directed 
migration of cells (Figure 4 A) (Solnica-Krezel, 2005). During mediolateral narrowing, cells 
become elongated to facilitate intercalation movements and simultaneous rostrocaudal 
elongation of the body axis (Keller and Shih, 1992). Directed migration of cells, on the other 
hand, is guided by medial and lateral formation of lamellipodia that attach to neighboring 
cells thereby promoting intercalation movements (Elul and Keller, 2000). Additionally, cell 
behaviors such as polarized cell division and apical-basal elongation of cells contribute to 
CE (Gong et al., 2004). It is well known that non-canonical Wnt signaling is required for 
mediolateral cell polarization that underlies CE movements; e.g. vangl2- deficient embryos 
show severe defects in body axis elongation (Heisenberg et al., 2000; Sepich et al., 2000; 
Tada and Smith, 2000). Moreover, downstream effectors of PCP signaling that comprise 
RhoA, Rac, and Cdc42 were shown to mediate migrative behavior of cells (Choi and Han, 
2002; Tahinci and Symes, 2003). 
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In general, asymmetric and polarized cell morphology is the basis for organization and 
maintenance of the function of several organs and tissues. This becomes apparent in the 
structure of nerve cells that are clearly polarized with dendrites on the one and axons on the 
other side of the cell body. However, also cells within a tissue plane often have to assume 
distinct polarization patterns, which is especially true for epithelia (Martin-Belmonte and 
Perez-Moreno, 2011). Importantly, the myocardium of the developing heart displays clear 
epithelial tissue characteristics such as apicobasal polarity at least until 96 hpf (Vanderploeg 
et al., 2012). 
 
 
 
Figure 4: Tissue morphogenesis is driven by diverse mechanisms of collective cell behaviors.  
(A) Mediolateral cell intercalation drives convergent extension (CE) during zebrafish gastrulation by spatial 
regulation of NMII. Shrinkage of ‘vertical’ junctions through anisotropic tension exerted by medial-apical 
actomyosin and polarized NMII (in red) and extension of ‘horizontal’ ones drives tissue elongation along the 
anteroposterior axis. Within epithelial tissues, clusters of (1) four or (2) more cells form during these movements. 
(B) Epithelial remodeling is characterized by these T1 transitions and formation of rosettes. T1 transitions mediate 
cell rearrangements in clusters consisting of four cells. Collectives containing five or more cells remodel via 
formation of multicellular rosettes that are resolved in direction of tissue extension. (C) Transmission of tension 
requires changes in adhesion by E-cadherin re-localization to junctions and spatial regulation of myosin 
phosphorylation through kinases such as Rho and ROCK (modified from: Tada and Heisenberg, 2012; Lecuit, 
2015). 
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Whereas mesenchymal tissue morphogenesis is mostly driven by cell intercalation and 
directed cell migration, rearrangements in apicobasally polarized epithelia are often 
regulated by additional mechanisms that have been characterized and defined as epithelial 
remodeling. In detail, epithelial remodeling describes the establishment of unique migratory 
patterns of apicobasally polarized cells that influence their position within planar polarized 
tissues guiding morphogenesis of many organs including lung, kidney, and the eye 
(Lienkamp et al., 2012; Rackley and Stripp, 2012; Zallen and Blankenship, 2008). Epithelial 
remodeling can be classified in two general modes that are directed by non-muscle myosin 
II (NMII)-conducted tensional changes of apical junctions. First, in a cluster of four cells 
shortening of the junction between two cells over the perpendicular axis of tissue extension 
leads to so called T1 transition that is completed by formation of a new junction along the 
axis of tissue elongation (Figure 4 B). Second, in groups of five to twelve cells the same 
mechanism leads to formation of flower-shaped multi-cellular rosettes (Figure 4 B) (Bertet et 
al., 2004; Blankenship et al., 2006). 
Shortening of apical junctions is mediated by actomyosin contraction that leads to further 
recruitment of myosin II to these junctions (Fernandez-Gonzalez et al., 2009). Additionally, 
E-cadherin endocytosis at apical junctions is required for NMII-mediated junctional shrinkage 
(Levayer et al., 2011). Thus, coordinated action of actomyosin and adhesion underlies tissue 
morphogenesis regulated by epithelial remodeling (Figure 4 C).  
1.4.2 Mechanical Forces During Tissue Morphogenesis 
Mechanical forces direct various cellular processes: epithelial sheets undergo dramatic 
changes during embryonic development, muscle contraction underlies the remodeling of 
connective tissue, and vasculogenesis is dependent on changes in blood pressure (Ateshian 
and Humphrey, 2012; Fournier et al., 2010; Halcox and Deanfield, 2007). The first 
mechanical model for epithelial morphogenesis emerged in 1980 when Odell and colleagues 
discussed efficient mechanisms of epithelial cell shape changes through force generation by 
apical subcortical bands of microfilaments (Odell et al., 1980). It is known that mechanical 
forces, which drive tissue morphogenesis, are typically generated by molecular motors and 
transmitted via cytoskeletal components and adhesion molecules within and between cells 
(Heisenberg and Bellaïche, 2013).  
One of the major requirements for force transmission is intercellular attachment generated 
through the formation of junctional complexes such as adherens and tight junctions. 
Adherens junctions (AJ) connect neighboring cell membrane and their actin cytoskeletons. 
This form of cell-cell adhesion is mainly dependent on members of the cadherin family that 
include classical cadherins (e.g. N-, E- and VE-Cadherin), protocadherins, and atypical 
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cadherins (e.g. Fat, Dachsous, Fmi). Homo- and heterophilic interactions between these 
transmembrane proteins of neighboring cells are mediated by their extracellular domains 
containing characteristic extracellular cadherin repeats (Yap et al., 1997). However, 
cadherins are not only required for adhesion between cells, but also for several aspects of 
tissue morphogenesis such as cell sorting, boundary formation, coordinated cell movements 
as well as the regulation of cell and tissue polarity (Halbleib and Nelson, 2006). These 
additional functions mainly rely on the interaction of the intracellular domain of cadherin with 
intracellular binding partners like the membrane associated components α- and β-catenin 
that transduce cadherin activity to the cytoskeleton to adjust actomyosin contractility (Harris 
and Tepass, 2010; Weis and Nelson, 2006). Here, tensile force was shown to strengthen the 
bond between cadherin, α- and β-catenin and actin filaments (Buckley et al., 2014). Both 
catenins were shown to be substantial for epithelial cohesiveness and transmission of 
tension within the epithelial sheet (Bazellières et al., 2015). 
Another crucial regulator of mechanical force transduction and intra- as well as intercellular 
tension is actomyosin. Actomyosin was first discovered during the 1940s in muscle, when it 
was observed that actin and myosin form highly organized bundles of filaments that 
constitute more than half of the total protein (Straub, 1942). Many years later, both proteins 
were detected in other cell types showing that actomyosin in muscle tissue was a specialized 
form of a common system. Actomyosin contractility is a key regulator of cell morphology and 
tissue morphogenesis (Lecuit et al., 2011). First, stability and changes of cell shapes are 
generated through a cortex of F-actin meshwork located beneath the plasma membrane that 
resists and generates force (Bovellan et al., 2014). Second, active contractile tension is 
generated by ATP hydrolysis within myosin to move along these F-actin filaments (Howard 
and Clark, 2002). Junction shrinkage during epithelial remodeling is dependent on both 
actomyosin contractility and decreased adhesion. However, constriction of intercellular 
myosin cables seems to be crucial, since mutations in NMII perturb rosette formation during 
Drosophila axis elongation (Simoes et al., 2010). 
NMII is a major regulator of the actomyosin tension that assumes several functions, including 
generation of cortical tension, mediating cytokinesis, and the regulation of cell shape 
changes during development, and needs to be therefore tightly controlled to maintain 
tensional homeostasis (Krendel, 2005; Vicente-Manzanares et al., 2009). The NMII 
hexameric molecule is formed by one pair of homodimerized heavy chains, two regulatory 
light chains (MRLC), and two essential light chains. Actomyosin contractility is regulated by 
dynamic phosphorylation of MRLC at the highly conserved amino acid residues T18 and S19 
in vertebrates. This is achieved through several signaling pathways including those 
downstream of the Rho-associated protein kinase (ROCK), the Myotonic dystrophy kinase-
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related Cdc42-binding kinase (MRCK, activated by Cdc42) and Myosin light chain kinase 
(MLCK, activated by Ca2+) (Matsumura, 2005). Moreover, activation of MRLC through 
phosphorylation is controlled via inhibition of Myosin phosphatase target subunit 1 (MYPT1) 
activity that is mediated by its phosphorylation through ROCK (Kimura et al., 1996). 
Mechanisms upstream of this complex network of kinases and phosphatases comprise the 
induction of small GTPases by Rho GEFs leading to enhanced ROCK function and activation 
of Formin and Formin-related proteins such as Daam (Nishimura et al., 2012). 
Cells need to sense physical constraints and exert mechanical forces to achieve organ-
specific shape, cell-fate and differentiation. The forces generated by above-mentioned 
mechanisms result in strain of proteins and membranes. This leads to transduction into 
biochemical signals mostly through tension-dependent removal of an auto-inhibitory domain, 
which induces conformational changes in binding pockets of protein-protein interactions that 
are under tension (Yusko and Asbury, 2014). Likely candidates that are currently discussed 
as sensors of mechanical force and tension include stretch activated ion channels, the 
cytoskeleton, cell adhesion sites including cell adhesion molecules (CAMs) such as 
cadherins and integrins, cytoskeleton-linking proteins such as vinculin and talin and signaling 
proteins such as focal adhesion kinase (FAK) (Franze et al., 2009; Moore et al., 2012; 
Renaudin et al., 2000). Furthermore, the nucleus itself was discussed previously to respond 
to changes in intracellular tension. Here, mechanoregulation at integrins within the cell 
membrane was described to direct forces through the cytoplasmic cytoskeleton to the 
nuclear cortex resulting in changes in gene transcription (Swift et al., 2013). 
Several studies explore mechanisms involved in force-dependent tissue morphogenesis. For 
instance, during vasculogenesis shear force exerted on endothelial cells generated by fluid 
flow ensures proper vessel formation (Freund et al., 2012). The significance of proper 
tensional homeostasis to achieve cell fate specification and differentiation was elucidated by 
the imitation of stem cell niches utilizing physiologically specific biomaterials and 
microfluidics. However, the understanding of the specific roles of mechanical forces in tissue 
morphogenesis, cell fate specification and differentiation remains incomplete. 
1.5 Mechanosensitive SRF Signal Transduction 
The serum response factor (SRF) was named after its function as a transcriptional regulator 
during the initiation of mitogenesis in response to serum-stimulation of various cultured 
mammalian cells (Norman et al., 1988; Treisman, 1986). Later, SRF was implicated in 
controlling morphogenetic movements and migration during embryonic development 
(Arsenian et al., 1998). This founding member of the MADS-domain containing family is 
highly conserved from fly to human and encoded by a single gene (Mueller and Nordheim, 
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1991; Shore and Sharrocks, 1995). Target genes of SRF share the presence of single or 
multiple copies of a CArG box – the consensus element CC[A/T]2A[A/T]3GG that binds SRF 
homodimers (Niu et al., 2007; Selvaraj et al., 2004; Sun et al., 2006; Zhang et al., 2005). In 
silico approaches have determined that the CArGome comprises more than 8000 
evolutionary conserved CArG elements (Benson et al., 2011). 
 
 
 
 
 
Figure 5: Two general SRF transduction cascades activate myogenic or growth response gene 
expression. (Left) SRF signaling responsible for myogenic and cytoskeletal gene expression is initiated by 
activation of Rho family GTPases that increase actin polymerization from monomeric G-Actin. Subsequent 
separation of G-Actin / MRTF complexes allows translocation of the MRTF cofactor into the nucleus where it 
binds and activates SRF. (Right) Activation of the MAP kinase pathway through Ras, Raf, MEK, and ERK 
phosphorylates the transcription factor TCF which leads to its translocation to the nucleus and binding to its own 
Ets DNA recognition site and SRF. This activates expression of ‘immediate early’ and growth response genes. 
 
SRF signal transduction acts on two distinct classes of target genes: (1) mitogen-responsive 
“immediate-early” and growth-related genes encoding signaling molecules, cytoskeletal 
components, and transcription factors, and (2) muscle specific genes expressed in cardiac, 
smooth and skeletal muscle (Figure 5) (Pipes, 2006; Sun et al., 2006). The interaction of 
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SRF with two families of signal-regulated and tissue-specific cofactors determines unique 
target gene expression.  
Firstly, members of the ternary complex factor (TCF) family of Ets domain proteins (e.g. Elk1) 
are activated by mitogen activated protein kinase (MAPK) phosphorylation that initiates rapid 
but transient expression of immediate-early genes like c-fos or by the Ras-Raf-MEK-ERK 
pathway that activates growth response genes (Treisman, 1994). Secondly, a signal-
regulated SRF cofactor family, the myocardin-related transcription factors (MRTFs and 
MALs), ensures transcription of many genes encoding actin isoforms or actin binding proteins 
(ABP) such as vinculin or myosin (Olson and Nordheim, 2010).  
Apart from the aforementioned two major cofactor families, other transcription factors have 
been implicated in SRF regulation. Positive regulation of SRF signal transduction is attained 
by members of the GATA family of zinc finger transcription factors as well as the Nkx2.5 
family of homeodomain proteins (Belaguli et al., 2000; Chen and Schwartz, 1996). 
Negatively acting SRF cofactors comprise the LIM-only protein FHL2, that antagonizes MAL-
SRF dependent transcription, and the cardiac-enriched homeodomain-only cofactor HOP 
(Chen et al., 2002; Philippar et al., 2004; Shin et al., 2002). 
SRF activation via the MRTF pathway is indispensible for cardiac muscle differentiation and 
the activation of smooth muscle contractile genes (Du et al., 2003; Wang et al., 2001). In 
mouse, SRF expression within the cardiac crescent is first observed when cardiac progenitor 
cells migrate to the midline to form a linear heart tube (Barron et al., 2005; Olson and 
Srivastava, 1996). During cardiogenesis the SRF target genes α-skeletal (acta1), α-cardiac 
(actc1) and α-smooth-muscle actin (acta2) are co-expressed in healthy myocardium and 
their abundance is dependent on the species, developmental stage, and pathological state 
(Boheler et al., 1991; Carrier et al., 1992). Here, the onset of cardiomyocyte differentiation is 
marked by acta2 expression, which is subsequently followed by acta1 and actc1 expression 
as development proceeds (Ruzicka, 1988). 
Cardiac development is marked by persistent and acute changes in myocardial tension 
throughout the formation and maturation of the heart. Previous studies showed that changes 
in tension mediate myogenic cofactor activity, providing a feedback mechanism for 
enhancing cytoskeletal strength (Somogyi and Rørth, 2004). Moreover, recent evidence 
emerged, that the SRF transduction pathway is regulated by actin dynamics and requires 
tensional homeostasis within tissues (McGee et al., 2011; Miano et al., 2006). 
Several studies suggest that SRF expression needs to be tightly controlled during cardiac 
development. Spatially restricted deletion of SRF in the embryonic heart results in thinning 
of the myocardial wall, severely disrupted sarcomeric structure and results in death of mice 
embryos at E11.5 (Niu et al., 2008; Parlakian et al., 2004). In gain-of-function studies cardiac-
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specific overexpression of wild-type or dominant-negative SRF resulted in heart failure due 
to severe changes in actomyosin composition (Zhang et al., 2001). 
1.6 Aim of the Study 
Establishing a functional cardiac syncytium requires coordinated tissue morphogenesis and 
formation of proper intercellular electrical coupling. The role of Wnt signaling during the 
morphogenesis of various organs (e.g. kidney and eye) has been studied extensively. 
Although several CHDs have been linked to deficiencies in Wnt signaling, its function during 
early cardiogenesis remains unclear. 
The aim of this study is to shed light on our understanding of mechanisms mediated by 
Wnt/PCP signaling that underlie the development of the chambered heart from the linear 
heart tube using the zebrafish animal model. In loss-of-function studies, it will address 
potential regulatory pathways that target the remodeling of early myocardium. Thus, the 
study aims at elucidating cellular processes required for establishing cardiac architecture, 
and effects of Wnt non-canonical PCP signaling on mechanisms guiding the morphogenesis 
of the early myocardium. Furthermore, it will address if and how the PCP pathway is involved 
in cardiomyocyte differentiation and cardiac maturation. 
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2 Results 
2.1 Ventricular Cardiomyocytes Acquire Regionally Specific 
Morphology During Cardiac Chamber Formation 
Proper morphogenesis of the two cardiac chambers from the primitive heart tube is crucial 
for the function of the zebrafish heart. At linear heart tube (LHT) stage the entire myocardium 
consists of a homogeneous cell population of small and circular cells. By the time the two 
cardiac chambers form, the atrial and ventricular cardiomyocytes acquire distinct 
characteristics; atrial cells become larger and form a squamous epithelium, while ventricular 
cells are much smaller and cuboidal. At the same time morphological and physiological 
differences between the outer (OC) and inner (IC) curvatures of the ventricle are established 
(Figure 6 A, OC – green, IC – red) that are important for proper cardiac function e.g. 
asymmetries in action potential propagation (Panáková et al., 2010). As the name suggests, 
OC and IC cardiomyocytes display different morphological characteristics depending on their 
position within the zebrafish ventricular chamber when measured at the cross-section at the 
level of the apical tight junctions (Auman et al., 2007; Scherz et al., 2008).  
 
 
 
Figure 6: Chamber formation induces regionally restricted cell shape changes. (A) Confocal images of two-
chambered hearts at 54 hpf stained for Alcam as a membrane marker were analyzed with Packing Analyzer 
software (Aigouy et al., 2010) for size and circularity of OC (green) and IC (red) cardiomyocytes. (B, C) Cells of 
the outer curvature become larger and elongated (n=239, area = 104 µm², circularity = 0.53), while cells of the 
inner curvature remain relatively small and rounded (n=210, area = 83 µm², circularity = 0.6). OC = outer 
curvature, IC = inner curvature. Scale bar = 10 µm. *** = P<0.001; t-test. 
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To corroborate the region-specific characteristics of these cells, a number of parameters 
such as circularity, size and cell orientation were measured by using open-source Packing 
Analyzer software that determines cellular outlines by utilizing the watershed algorithm 
(Aigouy et al., 2010). Here, in line with previous reports, cells of the OC are larger and less 
cuboidal compared to IC cardiomyocytes with an average area of 104 µm² and circularity 
value of 0.53, while the latter are 83 µm² in size and have a circularity value of 0.6 (Figure 6 
B, C). These data confirm that regionally specific changes in cardiomyocyte cell shape within 
the ventricle accompany cardiac chamber formation in zebrafish. 
2.2 Mechanisms of Epithelial Remodeling Underlie Cardiac 
Chamber Formation 
Formation of the two cardiac chambers from the primitive heart tube requires integration of 
cells that are added from the second pool of cardiac progenitors as well as expansion of the 
atrium and ventricle; an uncharacterized molecular and cellular process that to date is termed 
“cardiac ballooning” (Christoffels et al., 2000; Risebro and Riley, 2006; van den Berg and 
Moorman, 2009). It has been proposed that cell neighbor exchange through epithelial 
remodeling provides an efficient mechanism for the rearrangement of cells within a single 
layered epithelium during organ formation (Blankenship et al., 2006; Farhadifar et al., 2007; 
Villasenor et al., 2010). This process is marked by transitory states in which four (T1 
transition) or more cells (rosette) converge into a single vertex and subsequently resolve in 
the opposite direction, thus reshaping the tissue (Bertet et al., 2004; Fletcher et al., 2014; 
Tada and Heisenberg, 2012; Yu and Fernandez-Gonzalez, 2016). 
To determine whether mechanisms of epithelial remodeling underlie cardiac chamber 
formation, whole embryo time-lapse imaging of non-contractile hearts of tnnt2 morphant 
zebrafish embryos was performed during LHT transition to two-chambered state in a 
transgenic line Tg(myl7:lck-eGFP) that expresses membrane-tethered eGFP within 
cardiomyocytes. Snapshots of a movie depicted in Figure 7 follow over time one rosette 
within the ventricular myocardium that at t = 0 h (26 hpf) consisted of five cells that shared a 
central vertex. Within the next 5 h (31 hpf) this rosette resolves fully as new cell junctions are 
formed and cells change their position in respect to each other within the myocardium 
suggesting that cardiac ballooning is guided by cell rearrangements regulated through 
mechanisms of epithelial remodeling (Figure 7). 
As aforementioned, myocardial architecture differs significantly between LHT stage and after 
formation of the atrium and ventricle. Moreover, addition of cardiomyocytes from the SHF 
requires substantial incorporation of cells into the cardiac tube. 
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Figure 7: Whole embryo time-lapse imaging of resolving rosette in non-contractile tnnt2-deficient heart. 
At t = 0 the LHT (26 hpf) features a rosette consisting of five cells that share a common vertex (arrowhead). 
During the following 5 h this rosette resolves fully and new cell junctions are formed (arrowhead). Scale bar = 10 
μm. 
Live imaging showed that cardiac chamber formation is at least in part driven by epithelial 
remodeling. To quantify cell rearrangements within the zebrafish myocardium during 
chamber formation, transitory states where four (T1 transition) or more cells (rosette) 
converge into a central vertex were counted at distinct stages of cardiac development. To 
that end, hearts were fixed and stained for the transmembrane glycoprotein Alcam that 
served as a membrane marker at 26, 54, and 72 hpf (Figure 8 A-C). Quantification of 
transitory states was performed using the Packing Analyzer software (Aigouy et al., 2010). 
At 26 hpf transitory states are highly abundant within the myocardium of the LHT (n=11; 9.1 
transitions per 100 cells) (Figure 8 A, D). The number of transitory states is decreased 
significantly by 40% at 54 hpf after the two chambers have formed with 5.2 transitions per 
100 cells (n=10; P<0.01) (Figure 8 B, D). The presence of transitory states does not change 
significantly in the following 18 h (n=6; 4.5 transitions per 100 cells) (Figure 8 C, D). The data 
show that the number of transitory states is indicative of the state of myocardial remodeling. 
Moreover, the data suggests that mechanisms of epithelial remodeling drive cardiac chamber 
formation of the vertebrate heart within the first 54 h of development.  
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Figure 8: Epithelial remodeling guides cardiac chamber formation. (A-C) Confocal images of wild-type hearts 
at 26 hpf, 54hpf and 72 hpf stained for Alcam as a membrane marker with transitory states highlighted in red. (A, 
D) At LHT stage the myocardium features 9.1 transitory states per 100 cells (n=11). (B, D) After formation of the 
cardiac chambers the number of transitory states is decreased to 5.2 per 100 cells (n=10). (C, D) Hearts at 72 
hpf display on average 4.5 transitory states per 100 cells (n=6). Scale bar = 10 µm. *** = P<0.01; one-way 
ANOVA. 
 
2.3 PCP Guides Cardiac Chamber Formation by Targeting 
Mechanisms of Epithelial Remodeling 
2.3.1 Wnt11 and Wnt5b Control Cell Rearrangements 
Non-canonical Wnt signaling through both Wnt5 and Wnt11 was shown to be essential for 
proper cardiac development (Cohen et al., 2012; Pandur et al., 2002). In mice, both 
coordinate proper right ventricular OFT morphogenesis by targeting cytoskeletal 
organization (Zhou et al., 2007). Moreover, both were shown to be essential regulators of 
epithelial remodeling (Cervantes et al., 2009; Heisenberg et al., 2000). 
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Figure 9: Non-canonical ligands Wnt11 and Wnt5b govern epithelial remodeling during chamber 
formation. (A-C) Confocal images of hearts at 54 hpf stained for Alcam showing transitory states in red. (A) 
Hearts of wnt5b (n=6) and (B) wnt11 (n=5) deficient zebrafish show slight increase in transitory states. (C) Loss 
of both Wnt11 and Wnt5b significantly increases the number of transitory states (n=6). (D) Quantification of 
transitory states in slb, ppt, and slb/ppt double mutant. (E) Quantification of T1 transitions and rosettes in hearts 
with decreased levels of Wnt11 alone and both Wnt11 and Wnt5b. Scale bar = 10 µm. *** = P<0.001, one-way 
ANOVA. 
 
I have shown that changes in morphogenesis of the embryonic myocardium are reflected in 
the number of T1 transitions and rosettes seen early after cardiac chamber formation. To 
assess the function of Wnt ligands during embryonic cardiac remodeling the number of 
transitory states at 54 hpf was determined in the hearts of Wnt5b mutant pipetail (ppt) (Figure 
9 A), and the Wnt11 mutant silberblick (slb) (Figure 9 B). The data were corroborated by 
injection of morpholino oligonucleotides targeting transcription start sites (ATG sites) of both 
ligands. All data were compared to the number of transitory states in the hearts of wild type 
controls at 54 hpf. There was a mild increase in the number of T1 transitions and rosettes in 
slb (6.8 per 100 cells; n=5; n.s.) (Figure 9 B, D), ppt mutants (7 per 100 cells; n=6; n.s.) 
(Figure 9 A, D) and in wnt11 morphant hearts (6.4 per 100 cells; n=5; n.s.) (Figure 9 E). To 
investigate whether Wnt5b and Wnt11 can compensate for loss of function of the other and 
act redundantly, the number of transition states in hearts of slb/ppt double mutants was 
determined (Figure 9 C). Here, simultaneous loss of both Wnt11 and Wnt5b increased the 
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number of transitory states by approx. 25% to 8.5 per 100 cells (n=6; P<0.01) (Figure 9 C, 
D). The effect on cell rearrangements was confirmed in hearts where levels of both Wnt11 
and Wnt5b were reduced using subthreshold concentrations of morpholino (9.6 per 100 cells; 
n=6; P<0.01) (Figure 9 E). In summary, these findings suggest that non-canonical Wnt11 
and Wnt5b are either redundant or act synergistically to guide chamber formation through 
regulation of cell rearrangement process within the single-cell layered myocardium. 
2.3.2 PCP Pathway Core Components Regulate Cardiac 
Remodeling 
PCP proteins have been described in guiding cell intercalation movements and 
rearrangements in many instances (Roszko et al., 2009). The core PCP pathway 
components that are expressed in the heart comprise the transmembrane proteins Fzd7 and 
Vangl2 and the cytoplasmic proteins Dvl2 and Pk1 (Hamblet, 2002; Henderson et al., 2006; 
Katoh and Katoh, 2003; Yu et al., 2012). All core proteins have been implicated in epithelial 
remodeling during morphogenesis of several organs like lung and kidney, the ear, or during 
neural tube development (Sienknecht, 2015; Sokol, 2015). Loss of function studies in both 
mutants and by using morpholino knockdown of the aforementioned PCP core proteins 
showed differences in the presence of transitory states within the ventricular myocardium at 
54 hpf (Figure 10 A-D). The number of transitory states was increased in hearts of fzd7ae3 
mutant (8.6 per 100 cells; n=7; P<0.001) (Figure 10 A, E), pk1ac4 transheterozygous mutant 
(7.2 per 100 cells; n=5; P<0.05) (Figure 10 D, E) and dvl2 morphant (8.5 per 100 cells; n=7; 
P<0.01) (Figure 10 B, F), but not of vangl2m209 mutant (5.9 per 100 cells; n=6; n.s.) (Figure 
10 C, E) as compared to wild type (5.2 per 100 cells) (Figure 8 B, D). Importantly, 
quantification of transitory states in the hearts of putative null mutants of the core PCP 
components or in the hearts with their decreased levels using morpholino knockdown 
technology produced similar results (compare Figure 10 E and F). Here, fzd7a-morphant 
hearts showed highly increased amount of T1-transitions and rosettes with 10.6 transitory 
states per 100 cells (n=9; P<0.001) (Figure 10 F). Reduction in pk1a-levels led to mild 
increase in T1-transitions and rosettes (7.3 per 100 cells; n=6; n.s.) (Figure 10 F). In vangl2-
deficient hearts the number of transitory states was mildly reduced to 3.8 per 100 cells (n=9; 
n.s.) (Figure 10 F). This supports the idea that both methods can be used interchangeably 
in this context. Taken together, these results strongly indicate that PCP signaling regulates 
cardiomyocyte rearrangements by targeting mechanisms of epithelial remodeling during 
early stages of cardiac development. 
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Figure 10: Number of transitory states (red) is altered in PCP deficient hearts. (A-D) Confocal images of 
PCP-deficient hearts at 54 hpf stained for Alcam showing transitory states in red. (E) In fzd7a mutant hearts the 
number of transitory states is increased by approx. 2-fold. Loss of pk1a also increases amount of T1 transitions 
and rosettes. In vangl2-deficient hearts the number of transitory states is slightly decreased (NS). (F) 
Quantification of transitory states in PCP morphants corroborates data acquired using genetic  mutant approach. 
Scale bar = 10 μm. ** = P < 0.01, *** = P < 0.001; one-way ANOVA. 
 
Results 
 
27 
The increased presence of transitory states at 54 hpf in the absence of Fzd7a, Dvl2 and 
Pk1a can be explained by either their increased formation frequency or by the reduced ability 
of the cells to form new cell boundaries. To get more insight, the quantification of transitory 
states was performed at 26 hpf, assuming that an increase in T1 transitions and rosettes 
already at this early stage hints at increased frequency of rosette formation. Indeed, in hearts 
with decreased levels of Fzd7a, the number of transitory states is already slightly increased 
at LHT stage (Figure 11 B, D). In contrast, reduction in Vangl2 led to mildly decreased 
number of T1 transitions and rosettes (Figure 11 C, D). Changes in the effectiveness of cell 
rearrangements during early cardiogenesis seem to correlate at least partially with the overall 
shape of the chambered heart. While fzd7a mutant hearts that show more transitory states 
are elongated, vangl2 mutant hearts fail to elongate and form more rounded chambers 
(Figure 11 A, C). However, both mutants show defects in cardiac looping suggesting that 
cardiac chamber formation is regulated by additional mechanisms. 
 
 
Figure 11: Reduction in Fzd7a results in increased number of transitory states already at LHT stage.  
(A-C) Confocal images of hearts at LHT stage (26 hpf) stained for Alcam showing transitory states in red. (D) 
Quantification shows a slight increase of transitory states in fzd7a morphant (n=5; n.s.) compared to wild-type 
hearts (n=11), while reduction in vangl2 levels led to a mild reduction (n=6; n.s.). Scale bar = 10 µm; one-way 
ANOVA. 
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2.4 The PCP Pathway Controls FHF / SHF Contribution 
Ventricles of fzd7a deficient hearts were overall smaller and consisted of less 
cardiomyocytes. Measurements of cardiomyocyte size and circularity within OC and IC 
regions revealed that in fzd7a morphant hearts distinct regional differences between cells of 
these ventricular areas are not established (Figure 12 A, B). Cardiomyocytes with decreased 
levels of Fzd7a are overall smaller compared to vangl2 deficient or wild type cells with an 
average cell area of approximately 60 µm² (Figure 12 A). Furthermore, all ventricular cells in 
hearts with reduced levels of fzd7a are more rounded with circularity values comparable to 
those of wild-type IC cells (OC = 0.61, IC = 0.58; compare Figure 6 C with Figure 12 B). Loss 
of Vangl2 did not affect the establishment of ventricular OC and IC cardiomyocyte region-
specific morphologies (Figure 12 A, B). These data show that cardiomyocytes in hearts with 
reduced levels of Fzd7a retain the more rounded and smaller morphology of cells at LHT 
stage. Their failure to develop regional specification proposes a role for PCP signaling in 
differentiation processes during early cardiogenesis. 
 
Figure 12: Loss of Fzd7a results in failure to establish region-specific IC and OC cardiomyocyte 
morphologies. (A, B) Measurements of OC and IC cardiomyocyte size and circularity in wild type hearts (OC: 
n=241; IC: n=212), in Fzd7a-deficient hearts (OC: n=154; IC: n=145), or those with reduction in Vangl2 (OC: 
n=167; IC: n=171). (A) Significant differences in size between IC and OC cardiomyocytes as observed in wild 
type and vangl2-deficient hearts were lost in fzd7a-morphant hearts. Cardiomyocytes of the fzd7a-morphant 
ventricle are overall significally reduced in size (OC: 60 µm²; IC: 59 µm²) compared to wild type (OC: 103 µm²; 
IC: 83 µm²) and vangl2-deficient hearts (OC: 108 µm²; IC: 88 µm²). (B) Analysis of circularity in OC and IC regions 
of the ventricles reveals defects in OC cardiomyocyte elongation in fzd7a morphant hearts as cells are overall 
more circular and fail to establish regionally restricted differences in size and circularity. *** = P<0.001; t-test. 
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Studies in chicken and zebrafish revealed that the proliferation rate of cardiomyocytes of the 
LHT is minimal and that overall organ growth is achieved by addition of a second pool of 
differentiating cardiomyocytes from the SHF that ensures cardiac chamber formation (de 
Pater et al., 2009; Kelly, 2012; Mosimann et al., 2015; van den Berg and Moorman, 2009). 
In zebrafish these cells are integrated into the heart tube from both cardiac poles, which in 
ventricle comprises IC and OFT region in particular (de Pater et al., 2009; Mosimann et al., 
2015). Hearts with reduction or complete loss of fzd7a show decreased organ size and 
defects in regional specification of cardiomyocytes. To assess whether changes in SHF 
accrual in fzd7a morphant hearts contributed to the observed phenotypes a transgenic line 
was used that expresses GFP in a FHF specific manner under the draculin (drl) promoter 
[Tg(drl:eGFP)] (Mosimann et al., 2015).  
 
 
 
Figure 13: Dysregulation of the PCP pathway affects FHF / SHF ratio in 54 hpf hearts. (A-C) Confocal 
images of hearts at 54 hpf stained for myosin heavy chain (MHC) and expressing GFP under the draculin (drl) 
promoter that marks FHF specifically (A, D) In the uninjected control FHF portion makes up 40% of the ventricle. 
(B, D) FHF / ventricle ratio is increased to 48 % in fzd7a-deficient hearts. (C, D) In hearts with reduced levels of 
vangl2, the FHF composes 29% of the ventricle. Scale bar = 10 µm. ** = P<0.01, *** = P < 0.001 one-way ANOVA. 
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In hearts with reduced levels of either fzd7a or vangl2 the area of GFP-positive cells was 
measured in relation to the entire ventricular area (Figure 13 B, C, D). In wild-type hearts, 
the FHF accounts for 40 % of the ventricular chamber (Figure 13 A, D). Analysis of the FHF 
/ ventricle ratio showed that loss of Fzd7a increases FHF amount within the ventricular 
myocardium (48 %) (Figure 13 B, D), while loss of Vangl2 decreases the FHF contribution to 
the heart to 29 % (Figure 13 C, D). These results indicate that PCP mediates FHF / SHF 
specification or SHF cardiomyocytes accrual to the LHT. 
2.5 PCP Regulates Ventricular Tissue Architecture 
During chamber formation, ventricular cardiomyocytes not only acquire region-specific 
morphologies, but also assume distinct orientations within OC, IC, the OFT and the AV-
junction of the zebrafish myocardium. Using a customized version of the Packing Analyzer 
software, cell orientation within the ventricle was investigated to describe myocardial 
architecture in more detail. The program analyzes cardiomyocytes orientation within the 
aforementioned regions by placing a tangent on the respective cell in regard to the overall 
outline of the ventricle. It then relates the elongation tensor of the cardiomyocyte to the 90-
degree angle placed on this tangent. In wild type hearts, cells of the OC and IC assume a 0-
degree orientation, those at the AV-junction and within the OFT region are oriented in a 90-
degree angle (Figure 14).  
As aforementioned, the overall ventricular morphology of fzd7a and vangl2 mutant hearts is 
defective with more elongated or more rounded chambers, respectively. To investigate the 
involvement of Wnt non-canonical signaling in establishing proper ventricular form, analysis 
of cardiomyocytes orientation in loss-of-function studies targeting the core PCP proteins 
Fzd7a, Dvl2, Vangl2, and Pk1a was performed. Here, loss of Fzd7a resulted in severe 
disruption of cardiomyocytes orientation, especially in regions close to the OFT (Figure 14). 
Decreased levels of Dvl2, Pk1a and Vangl2 resulted mainly in increased variability of cell 
orientation within the OFT region (Figure 14). For statistical analysis of angle distribution in 
the OFT region Rayleigh’s test was performed to assess significance of the mean direction 
by using a concentration parameter of a circular distribution. Here, low values of Rayleigh’s 
R represent highly concentrated values with little distribution. The mean angle of OFT 
cardiomyocyte orientation in wild type hearts is 92,27 degrees with low distribution 
(Rayleigh’s R = 9.25 x 10-9). In contrast, morpholino knockdown of fzd7a results in a shift of 
the mean angle to 96,01 degrees with higher variance (Rayleigh’s R = 6.5 x 10-2). In hearts 
with complete loss of Fzd7a the mean angle of cardiomyocyte orientation in the OFT region 
is even more shifted to 118.42 degrees (Rayleigh’s R = 1.69 x 10-1).  
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Figure 14: Loss of PCP core components results in OFT defects. Cardiomyocytes assume distinct 
orientations within the ventricular chamber. Angles are defined relative to a 90-degree angle above a tangent 
placed on the outline of the ventricle. Wild type cardiomyocytes of the AV (n = 92) and OFT region (n = 86) are 
positioned in a 90-degree angle, while cells of the IC (n = 57) and OC (n = 295) assume a 0-degree angle. Loss 
of Fzd7a leads to severe defects in cardiomyocyte orientation within the OFT (n = 89), the OC region close to the 
OFT (n = 84) and the IC (n = 162). Similarly, defects in OFT cardiomyocyte arrangement are entailed by 
decreased levels in Dvl2 (n = 72), Vangl2 (n = 47), and Pk1a (n = 66). 
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While the mean angle of OFT cardiomyocytes is not altered in vangl2 mutant hearts, the 
variability of angles is very high (90.04 degrees; Rayleigh’s R = 2.34 x 10-1). Similar effects 
are observed in dvl2 morphant (89,52 degrees; Rayleigh’s R = 7.82 x 10-3) and pk1a 
morphant hearts (93.45 degrees; Rayleigh’s R = 1.36 x 10-2). Taken together, data show that 
changes in ventricular cell shape that are accompanied by changes in cardiomyocyte 
orientation, and are mediated by cell rearrangements correlate with the characteristic bean-
like shape of the ventricle. Moreover, these data underline the importance of functional PCP 
signal transduction for proper myocardial morphogenesis of the vertebrate heart. 
 
2.6 PCP Controls Cellular Rearrangements by Affecting 
Cytoskeleton 
2.6.1 PCP Does Not Affect N-Cadherin Localization 
Junctional remodeling during morphogenesis is guided by complex mechanisms involving 
actomyosin modulation as well as changes in adhesion mediated through cadherin 
localization, turnover and endocytosis (Nishimura and Takeichi, 2009). Several studies 
suggest that PCP signaling is targeting cell-cell adhesion and cytoskeletal rearrangements 
in various developmental contexts (Babayeva et al., 2011; Classen et al., 2005; Nagaoka et 
al., 2014; Ulrich et al., 2005; Zallen, 2007). For instance, during the formation of the zebrafish 
ciliated laterality organ inhibition of both Wnt11 and Pk1a reduced intercellular adhesion 
leading to defective Kupffer’s vesicle lumen expansion (Oteiza et al., 2010). The remodeling 
of junctions is at least in part dependent on conformational changes of cadherin (Hong et al., 
2011). In the myocardium of the developing heart the only classical Cadherin expressed is 
N-Cadherin (Linask, 1992). Loss of N-Cadherin is embryonic lethal and misexpression of 
Cadherins during embryonic development leads to severe cardiomyopathy (Ferreira-
Cornwell et al., 2002; Luo et al., 2001). 
Quantification of T1 transitions and rosettes in hearts with defective PCP signaling revealed 
that epithelial remodeling underlies myocardial morphogenesis and cardiac chamber 
formation. However, it was still unclear whether PCP mediates these processes by changes 
in adhesion or tension through actomyosin modulation. To assess whether changes in 
cellular rearrangements are due to differences in adhesion processes, localization and 
abundance of N-Cadherin was determined in hearts with defective PCP signaling (Figure 15 
A-C).  
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Figure 15: Localization and abundance of N-Cadherin is not changed in PCP-deficient hearts.  
(A-C) Confocal images of hearts at 54 hpf stained for N-Cadherin (N-Cad). (A) In wild-type hearts N-Cad localizes 
uniformly to basolateral cell membranes. (B, C) In both fzd7a- and vangl2-deficient hearts N-Cad localization and 
abundance were unchanged compared to wild-type hearts. Scale bar = 10 μm. 
 
At 54 hpf N-Cadherin localized uniformly to the basolateral membrane both in wild type 
hearts (Figure 15 A) and hearts with decreased levels of Fzd7a (Figure 15 B) or Vangl2 
(Figure 15 C). Furthermore, no apparent change in N-Cadherin amount was detected within 
the ventricular myocardium between wild type and Fzd7a- and Vangl2-deficient hearts. Thus, 
these data show that adhesion processes targeted by PCP signaling are most likely not 
driving cardiac remodeling suggesting that PCP signaling rather acts on actomyosin 
structures. 
2.6.2 PCP effects on actomyosin 
Many cytoskeletal components including microtubules and actomyosin filaments are 
involved in the generation of cell shape, and thus affect tissue mechanics (Booth et al., 2014; 
Huber et al., 2015). Hence, changes in cell shape reflect differences in actomyosin 
organization and can be deployed to describe effects on these structures. To address 
whether PCP targets cytoskeletal organization during cardiac chamber formation, single 
cardiomyocyte morphology within the ventricular chamber at 54 hpf was visualized. To that 
end, cardiomyocyte specific membrane-tethered eGFP (myl7:lck-eGFP) was transiently 
expressed in wild type hearts (Figure 16 A) or in hearts with reduced levels of fzd7a  
(Figure 16 B) or vangl2 (Figure 16 C). Reduction in Fzd7a increased basal protrusion 
formation and showed rounded apical morphology of cardiomyocytes indicating that these 
cells are apically constricted within the myocardium (Figure 16 B). Vangl2 knockdown did 
not affect cardiomyocyte morphology as severely. However, cells appear to display an overall 
smoother cell surface compared to wild-type cardiomyocytes and expand to a greater extent 
over the apicobasal axis (Figure 16 C). 
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Figure 16: Cellular morphology is altered upon Fzd7a and Vangl2 knockdown. (A-C) Maximal confocal 
depth projections of single cells expressing membrane-associated eGFP (transient expression of myl7:lck-eGFP) 
depicting basal parts of cardiomyocytes in white/yellow and apical parts in blue/magenta. (A) Wild type OC 
cardiomyocytes show elongated morphology with few cell protrusions. (B) Cardiomyocytes of fzd7a morphant 
hearts form numerous pronounced basal protrusions and are rounded apically. (C) Reduced levels of Vangl2 
mildly affect cardiomyocyte shape with overall slightly smoother surfaces and increased expansion over the 
apicobasal axis. Scale bar = 5μm. 
 
Effectors of the PCP pathway were shown to spatially organize epithelial actin-based 
protrusions (Georgiou and Baum, 2010). Increased formation of basal protrusions in hearts 
with decreased levels of Fzd7a hints at local changes in actin branching morphology. 
Through transient expression of actin-bound RFP effects of defective PCP signaling on actin 
structures were investigated.  
 
 
Figure 17: F-Actin is affected in fzd7a and vangl2 morphant hearts. (A-C) Maximal confocal depth projections 
of sparsely-labeled cardiomyocytes at 54 hpf expressing actin-bound RFP (transient expression of myl7:lifeact-
RFP) depicting basal parts of cardiomyocytes in white/yellow and apical parts in blue/magenta. (A) F-Actin is 
organized in structured fibers within wild-type cardiomyocytes, and is visible in cell protrusions and along cell 
cortex. (B) F-Actin in fzd7a-deficient hearts is disorganized forming increased number of basolateral protrusions 
within individual cardiomyocytes. (C) In hearts with decreased levels of Vangl2, F-Actin fibers are highly organized 
within the cardiomyocyte cytoplasm, and the cortical F-Actin seems to be less prominent. 
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Here, wild type OC cardiomyocytes (Figure 17 A) were compared to those with loss of Fzd7a 
(Figure 17 B) or Vangl2 (Figure 17 C). In wild type cardiomyocytes filamentous actin (F-actin) 
is visible to be organized in fibers along cell cortex and in cellular protrusions. The absence 
of Fzd7a resulted in disorganized of actin-based structures, and showed that basal 
protrusions are predominantly formed by F-actin (Figure 17 B). Conversely, loss of Vangl2 
resulted in increased organization of F-actin with actin filaments aligning across cells, while 
cortical F-actin seems to be reduced (Figure 17 C). 
 
Cells in culture that have no or little contact to neighboring cells behave differently to cells 
organized within tissues, although several cell types such as MDCK cells display clear 
characteristics of polarity. In cultured breast cancer cells PCP core proteins were shown to 
assume distinct compartmentalized distribution at the plasma membrane (Luga et al., 2012). 
Here, as well as in several other cancer cell lines PCP core proteins control protrusive activity 
(Asem et al., 2016). To investigate the effects of defective PCP signaling in cardiac cells that 
are not organized into tissues, H9c2 rat myoblasts were treated with siRNA against fzd7a 
(Figure 18). This cell line expresses all core components of Wnt non-canonical PCP signaling 
(Rharass T., unpublished). While the untreated H9c2 cells display highly organized F-actin 
fibers (Figure 18 A), reduction in fzd7a levels by siRNA led to formation of long protrusions 
and disruption of F-actin (Figure 18 B) structures showing that effects on cytoskeletal 
components are not specific to zebrafish cardiomyocytes. 
 
 
Figure 18: Loss of Fzd7a results in formation of long protrusions in H9c2 rat cardiomyoblasts.  
(A) Untreated control cell show highly organized F-Actin structures. (B) Knockdown of fzd7a induces formation of 
long protrusions and disorganization of F-Actin fibers. Scale bar = 20μm. 
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The data shown in the previous sections clearly suggest that PCP targets actin organization 
to affect cell shape. Epithelial remodeling is characterized by junctional enrichment of both, 
actin and myosin (Bertet et al., 2004). Specifically, phosphorylation and proper localization 
of the regulatory light chain of NMII (MRLC) guides constriction of intercellular myosin cables 
that facilitate rosette formation (Simoes et al., 2014). To that end, the importance of pMRLC 
during early cardiac remodeling was investigated by determining its localization within the 
early myocardium at 54 hpf. While in wild-type embryos pMRLC localizes laterally to cell-cell 
junctions (Figure 19 A), it is mislocalized to the basal side of cardiomyocytes in both fzd7a 
and wnt11/wnt5b deficient hearts  
(Figure 19 B, C). This further corroborates that the PCP pathway regulates proper 
localization of actomyosin, which is pivotal to cardiac remodeling. 
 
 
 
 
Figure 19: Reduction of Fzd7a and non-canonical Wnt ligands affects pMRLC localization.  
(A-C, A’-C’) Confocal images of OC regions of hearts at 54 hpf stained for Alcam (red) and pMRLC (green).  
(A, A’) In wild-type hearts pMRLC localizes laterally to junctions. (B, B’) In hearts with reduced levels of fzd7a 
pMRLC is mislocalized to basal structures of cardiomyocytes (arrowheads). (C, C’) Similarly, reduction in 
Wnt11/Wnt5b leads to basal pMRLC mislocalization (arrowheads). Scale bar = 10 µm.  
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2.7 The PCP Pathway Regulates Localized Tension 
2.7.1 pMRLC and G-Actin Translocate from Nucleus to Membrane 
During Early Cardiogenesis 
In epithelial tissues cells locally produce the required energy to remodel cell contacts by 
forming actomyosin cables that span two or more cell-cell boundaries (Fernandez-Gonzalez 
et al., 2009). This active process involves a minimum of four cells, and can include up to 
twelve cells, connected by supracellular contractile cables (Röper, 2014). 
 
Figure 20: During cardiac remodeling pMRLC localization within the ventricle changes from nuclear 
compartment to cell junctions. pMRLC translocates from nucleus to membrane between 26 and 28 hpf and 
accumulates at the junctions, while its unphosphorylated form is mainly localized at the plasma membrane.  
(A-E) Wild-type hearts stained with phospho-specific (Ser20) antibody against pMRLC and (F-J) its 
unphosphorylated form at early stages of heart tube remodeling. At 54 hpf both localize to the sarcomeres (E, J). 
(A’-J’) Corresponding merged images of pMRLC (A’-E’) or MRLC (F’-J’) in green and plasma membrane stained 
for Alcam in red. Scale bar = 10 μm. 
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Hearts at LHT stage were stained for pMRLC to investigate its localization and amount during 
cardiac remodeling and determine if localized tension is underlying cardiomyocyte 
rearrangements. Changes in pMRLC localization from the nuclear compartment to junctions 
were observed. In detail, at LHT stage pMRLC is predominantly localized within the nucleus 
at 24 hpf and translocates to cell junctions of T1 transitions and rosettes before 30 hpf (Figure 
20 A-D, A’-D’), thus at the time of cardiac remodeling. This translocation is highly specific to 
pMRLC, as we never observed its non-phosphorylated form in the nucleus (Figure 20 F-J, 
F’-I’). At 54 hpf both MRLC and pMRLC accumulate to sarcomeric structures to take part in 
sarcomerogenesis (Figure 20 E, E’, J, J’) (Kamm and Stull, 2001). These and all other 
subsequent data of pMRLC could be reproduced only with the antibody batch Abcam ab2480 
(GR-143423-3), and further experiments are required to corroborate these findings. 
 
Actin and myosin are predominantly known for their function as major components of the 
cytoskeleton that take over structural and regulatory functions in the cytoplasm and at the 
cell cortex. However, recent studies increasingly focused on their role in the nucleus. Both 
actin and multiple myosins were already described to be involved in processes within the 
nuclear compartment. Here, nuclear myosin I (NMI) is the best studied myosin taking part in 
transcription regulation through interaction with RNA polymerases I and II, and molecular 
machinery involved in DNA damage repair, and chromosome translocation (Hofmann and 
de Lanerolle, 2006; Hu et al., 2008; Novak and Titus, 1997; Ye et al., 2008). NMII, and 
especially nuclear-specific phosphorylation of myosin, was never described or implicated in 
nuclear mechanisms before. In contrast, recent studies focus extensively on nuclear actin 
functions. Nuclear actin usually does not form filaments, but instead is almost exclusively 
found in its globular form or in short oligomers, and is referred to as G-actin (McDonald et 
al., 2006; Pederson, 2008). Several studies show that G-actin is involved in basically all steps 
of transcription, especially ensuring transcription through RNA polymerase I and II and 
mediating mRNA export (Grummt and Pikaard, 2003; Percipalle et al., 2001). Changes in 
nuclear localization of pMRLC prompted us to explore the localization of G-actin during 
chamber formation and whether it also undergoes nuclear export during cardiac remodeling. 
Indeed, staining for G-actin using fluorescently labeled DNaseI that selectively binds to 
globular actin revealed its predominant localization in the nucleus at 24 hpf and its 
subsequent translocation to cell cortex within the following 6 h (Figure 21 A-D, A’-D’). 
Summarizing, at LHT stage both pMRLC and G-actin translocate out of the nucleus to the 
cell cortex suggesting specific function of actomyosin within the nucleus at different stages 
during cardiac remodeling. 
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Figure 21: G-Actin localization switches from nuclear to cell cortex between 24 hpf and 30 hpf.  
(A-D, A’-D’) Confocal pictures of hearts during different stages of LHT remodeling stained for G-Actin (green) and 
the nucleus (DAPI-blue). G-Actin is located within the nuclear compartment at 24 hpf. In the following hours it is 
translocated to filamentous structures mainly located at the cell periphery (compare A, A’ with D, D’). 
 
2.7.2 Changes in pMRLC Affect Nuclear Tension and LMNA 
Localization 
Changes in cytoskeletal organization affect tensional homeostasis within the myocardium. 
Recently, tissue stiffness was shown to strongly correlate to nuclear tension and gene 
regulation as cells sense, translate, and transmit mechanical cues from the cytosol and the 
membrane to the nucleus (Buxboim et al., 2014; Swift et al., 2013). Mechanical forces alter 
the transcription of Lamin A/C (LMNA), and the stability of the encoded protein, distorting the 
nuclear envelope resulting in changes in transcriptional regulation. An increase in LMNA 
activates SRF signal transduction to induce myogenic differentiation (Swift et al., 2013). 
It is feasible to assume that nuclear shape can provide insight into the status of nuclear 
tension in the similar manner as cell shape, and that nuclear localization of pMRLC affects 
the tension within the nucleus. To that end, solidity of nuclear shapes was determined as a 
means to measure nuclear tension (Figure 22 A-C). The solidity value describes the actual 
shape of a 2D object in relation to an ellipse that is fitted to its boundaries (schematic in 
Figure 22 C).  
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Figure 22: Nuclear shape and LMNA localization within myocardium change during cardiac remodeling. 
(A, B) Confocal images of myocardial nuclei in hearts at 24 hpf and 30 hpf show differences in nuclear shape. 
(C) Solidity measures the area of an ellipse fitted to the nuclear outline against the convex area of the nuclear 
shape. Solidity is increased at 24 hpf reflecting rounder shapes of nuclei. Nuclei at 24 hpf (n=60) are rounder, 
and more solid than nuclei at 30 hpf (n=104). (D, E; D’, E’) Confocal images show changes in LMNA distribution 
within myocardial nuclei during cardiac remodeling. LMNA is highly abundant within the whole nuclear 
compartment at 24 hpf, but localizes distinctly to the inner nuclear membrane at 30 hpf. Scale bar = 5 µm. *** = 
P < 0.001; t-test. 
 
At 24 hpf high amounts of nuclear pMRLC correlate with rounded shape of nuclei  
(Figure 22 A, C). With translocation of pMRLC out of the nucleus at 30 hpf, nuclear shape 
becomes irregular, reflected by a reduction in solidity (Figure 22 B, C). These data suggest 
that phosphorylation of MRLC within the nucleus or at least its presence in phosphorylated 
form increases tension within this compartment. Recent studies reveal that changes in 
nuclear tension are accompanied with altered LMNA abundance and localization at the inner 
nuclear membrane that correlate strongly to differentiation of specific cell types  
(Swift et al., 2013). In wild-type hearts LMNA is located diffusely within the nucleus at  
24 hpf and distinctly to the inner nuclear membrane at 30 hpf suggesting changes in nuclear 
stiffness (Figure 22 D, D’, E, E’). 
2.7.3 PCP Pathway Components Regulate pRMLC Localization and 
Activity 
Dynamic interactions between PCP core components and the actomyosin cytoskeleton have 
been described repeatedly (Wallingford, 2012). Already in 2001 it was shown that PCP alters 
MRLC contractility through activation of the small GTPase Rho and subsequent ROCK-
dependent phosphorylation events (Figure 24) (Winter et al., 2001). 
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Figure 23: Changes in PCP signal transduction affect pRMLC localization and abundance.  
(A-E’) Confocal images of the myocardium at 26 hpf stained for Alcam (red) and pMRLC (green). pMRLC protein 
amount is increased in fzd7a (B, B’) and decreased in dvl2 (C, C’) morphant hearts, while down-regulation of 
Vangl2 (D, D’) and Pk1a (E, E’) changes its localization. Scale bar = 10 μm. 
 
To determine effects on pMRLC localization and abundance, PCP-deficient hearts were 
analyzed at 26 hpf when pMRLC is located both within the nucleus and at the cell membrane. 
Here, fzd7a and dvl2 morphant hearts show strong reduction in pMRLC amount (Figure 23 
B, B’, C, C’). In contrast, reduction in Vangl2 or Pk1a levels resulted in changes of pMRLC 
localization. In vangl2 morphant hearts pMRLC localizes exclusively to filamentous 
structures mainly at the cell membrane, while it is almost exclusively located to the nuclear 
compartment in hearts with reduced levels of Pk1a (Figure 23 D, D’, E, E’). This finding 
indicates that PCP undertakes two distinct roles in pMRLC regulation: (1) While Fzd7 and 
Dvl2 control the amount of MRLC phosphorylation (2) Vangl2 and Pk1 regulate pMRLC 
translocation or spatially restricted MRLC phosphorylation. 
2.7.4 Nuclear Export of pMRLC Requires Mylk3 Activity 
Changes in PCP signaling affect pMRLC abundance as well as localization to either the cell 
membrane or the nuclear compartment. Changes in pMRLC abundance in PCP-deficient 
hearts suggest that regulation of upstream kinase activity could be affected. MRLC activity 
is positively and negatively regulated by various kinases and phosphatases (Figure 24) 
(Clark et al., 2007). Among these, the Rho-associated protein kinase (ROCK) and the Myosin 
light-chain kinase (MLCK) have been studied most extensively. While ROCK is known to be 
regulated by PCP signaling, MLCK acts as a Ca2+ dependent kinase activated by binding of 
Ca2+ to calmodulin (Kamm and Stull, 2001; Shimizu et al., 2006).  
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Figure 24: Phosphorylation of MRLC is mainly regulated 
through the interplay of the kinases MLCK, ROCK, and the 
phosphatase MYPT. Both ROCK and MLCK phosphorylate 
MRLC directly. Additionally, ROCK regulates MRLC 
phosphorylation indirectly through inhibition of MYPT, which 
dephosphorylates pMRLC.  
 
 
 
Since the PCP pathway is a known activator of 
Ca2+ signaling, it is reasonable to assume PCP signaling might act as an effector of MLCK 
activity. Three types of muscle MLCKs have been identified: smooth muscle (smMLCK), 
skeletal (skMLCK), and cardiac (cMLCK) MLCK, which are products of genes mylk1, mylk2, 
and mylk3, respectively (Chan et al., 2008; Takashima, 2009; Watterson et al., 1999). The 
cardiac specific MLCK (Mylk3) contains a unique N-terminal sequence (Chan et al., 2008).  
 
 
Figure 25: Localization of phosphorylated MRLC is regulated by Mylk3. (A-C, A’-C’) Confocal images of OC 
region of hearts at 54 hpf stained for pMRLC (green) and Alcam (red). (A, A’) In wild-type hearts at 54 hpf pMRLC 
localizes to sarcomeric structures along the cell membrane. (B, B’) In hearts treated with ROCK inhibitor Y27623 
the level of pMRLC is reduced drastically. (C, C’) Decreased levels of Mylk3 lead to accumulation of pMRLC 
within the nuclear compartment of the zebrafish myocardium. 
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To investigate the role of kinases that regulate MRLC activity in the context of cardiac 
remodeling, function of both upstream regulators ROCK and MLCK was inhibited  
(Figure 25 A-C, A’-C’). Dissected hearts at 54 hpf were treated for 1h with the ROCK inhibitor 
Y27623 leading to decreased overall pMRLC abundance (Figure 25 B, B’). In contrast, 
reduction in Mylk3 levels via morpholino knockdown increased nuclear localization of pMRLC 
with concomitant reduction in its sarcomeric localization  
(Figure 25 C, C’). This finding reveals that pMRLC activity within the myocardium is regulated 
by upstream kinases through either abundance or localization. 
2.8 Pk1a is a Potential Nuclear Transporter 
2.8.1 Pk1 Localizes to Nucleus During Cardiac Remodeling 
Changes in localization of pMRLC to the nuclear compartment observed in pk1a- and mylk3-
deficient hearts suggest a novel function of PCP-signaling and downstream kinases in 
targeting nuclear transport. Pk1 is a PET and LIM domain containing protein that features 
several nuclear localization sites (NLS) as well as a C-terminal farnesylation motif CAAX that 
was shown to facilitate association with the membranes (Figure 26) (Ahearn et al., 2011). 
The N-terminal PET domain has been suggested to play a role in protein-protein interactions 
with proteins involved in planar polarity signaling or organization of the cytoskeleton (Gubb 
et al., 1999). The following LIM domains are zinc finger structures that were found in several 
types of proteins, including transcription factors and kinases that play essential roles in a 
diverse set of developmental processes such as cytoskeletal organization, cell lineage 
specification and organogenesis (Bach, 2000). Interestingly, the Pk1 nuclear localization is 
not only facilitated by NLS domain, but also by its C-terminal farnesylation motif (Mapp et al., 
2010). 
 
Figure 26: Pk1 is a LIM-domain containing protein with several nuclear localization signals (NLS). The N-
terminal PET and LIM domains have been suggested to play a role in protein-protein interactions with proteins 
involved in planar polarity signaling or organization of the cytoskeleton. Nuclear localization is facilitated by 
nuclear localization sites (NLS) and CAAX, a farnesylation signal, that also mediates Pk1 membrane binding. 
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Figure 27: Pk1 is predominantly localized in the nucleus at 26 hpf and both at the cell membrane and in 
the nucleus at 54 hpf. Localization of Pk1 at 26 hpf (green in A, greyscale in A’) and at 54 hpf (green in B, 
greyscale in B’) in wild-type hearts. Myocardial plasma membrane is stained for N-Cadherin (red in A, B). Scale 
bar = 10 μm. 
 
Several studies provided evidence that Pk1 is directly interacting with the nuclear 
transcriptional repressor RE1-silencing TF (REST), which is involved in the repression of 
neuronal genes in non-neuronal cells and the regulation of neuronal differentiation (Shimojo 
and Hersh, 2003; Shimojo and Hersh, 2006). In addition, during facial branchiomotor neurons 
migration, Pk1b isoform regulates the nuclear localization of the REST via its C-terminal 
farnesylation motif (Mapp et al., 2010; Yang et al., 2014). Thus, it has been proposed that 
Pk1 can function as a nuclear transporter (Mapp et al., 2010). 
First, to assess whether Pk1 might play a functional role in the nuclear compartment its 
localization in the developing myocardium was analyzed by immunostaining with an antibody 
specific to Pk1a and Pk1b. 
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Figure 28: In H9c2 rat cardiomyoblasts Pk1 accumulates within the nucleus and co-localizes with 
filamentous actin (F-Actin). (A-A’’) Confocal images of H9c2 rat cardiomyoblasts stained for Pk1 (green in A, 
greyscale in A’), F-Actin (red in A, greyscale in A’’), and the nucleus (blue in A). Scale bar = 20 μm. 
 
At LHT stage Pk1 localizes predominantly to the nucleus of ventricular cardiomyocytes with 
little protein at the cell membranes (Figure 27 A, A’), while at 54 hpf after completed chamber 
formation Pk1 localizes in presumably equal amounts to the cell membrane and the nuclear 
compartment (Figure 27 B, B’). These data suggest, that Pk1 may be involved in 
mechanisms within the nucleus during early cardiac development and that its role could 
change after the two chambers have formed. 
Next, to corroborate the data and to resolve the subcellular localization of Pk1 in greater 
detail, rat H9c2 cardiomyoblasts were stained for Pk1. Here, the protein co-localized with 
actin filaments and accumulated within the nucleus (Figure 28). This suggests that Pk1 
nuclear localization is not specific to zebrafish cardiomyocytes, but can be observed in 
cardiomyocytes of different species. This enforces further the hypothesis that Pk1 has a role 
in nuclear processes. 
2.8.2 SRF Localizes to Nucleus During Cardiac Remodeling 
Cardiac muscle differentiation and maturation is regulated by several signaling pathways 
including mechanosensitive SRF signaling. Nuclear localization of pMRLC, G-actin and Pk1 
in the early LHT myocardium and their subsequent translocation to the cytoplasm, formation 
of actomyosin cables followed by sarcomere formation, and Pk1 actin association suggests 
a role of these proteins not only in the cardiac chamber remodeling, but also in the maturation 
of the contractile myocardium. First, G-actin was implicated in activation of SRF/MRTF-A 
signaling, which is pivotal to myogenic and cytoskeletal gene expression in cardiac, smooth 
and skeletal muscle (Sun, 2005).  
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Figure 29: SRF translocates from nucleus to sarcomeres between 24 hpf and 72 hpf. (A-D) Confocal images 
of wild type hearts at different stages during cardiac development stained for SRF and Alcam. (A, B) At LHT stage 
SRF is highly abundant in the nucleus. (C) After chamber formation is completed SRF localizes not only in the 
nucleus, but also to sarcomeric structures. SRF remains more abundant within IC cardiomyocytes (full 
arrowheads) compared to OC cardiomyocytes (empty arrowheads). (D) Nuclear localization of SRF is further 
diminished at 72 hpf. Scale bar = 10 µm. 
 
Secondly, previous studies implicated other members of the LIM protein family in 
mechanisms regulating muscle-specification. Specifically, members of the CRP family were 
shown to interact with the SRF and members of the GATA family to achieve smooth-muscle 
differentiation (Chang et al., 2003). Lastly, changes in intracellular localization of pMRLC are 
likely accompanied by differences in local tension as indicated through decreasing solidity 
from early LHT stage to the beginning of cardiac chamber formation (Figure 22 A-C). 
Tensional homeostasis and mechanosensitivity was linked to SRF signaling on various 
occasions (McGee et al., 2011; Somogyi and Rørth, 2004).  
To investigate the role of SRF signaling during cardiac chamber formation in more detail, the 
early zebrafish myocardium was stained for SRF at different stages. During LHT stage, at 24 
hpf and 30 hpf, SRF is clearly localized within the nucleus of the ventricular cardiomyocytes 
(Figure 29 A, B). In the course of cardiac chamber formation SRF translocates from the 
nucleus to sarcomeric structures. At 54 hpf, SRF can be detected within the nuclei of the 
ventricular cardiomyocytes to a much lesser extent, with cells at the inner curvature often 
retaining more SRF than those of the outer curvature (Figure 29 C, arrowheads). At 72 hpf, 
after chamber formation is completed, SRF signal in the ventricular nuclei is further depleted 
(Figure 29 D). From 54 hpf onwards, SRF is clearly localized to sarcomeric structures of 
cardiomyocytes (Figure 29 C, D).  Thus, SRF behaves similarly in regard to nuclear 
localization and translocation to the cytosol when compared to pMRLC, G-actin and Pk1, 
further enforcing the potential role of these proteins in cardiac muscle maturation. 
Results 
 
47 
2.8.3 Pk1a and Mylk3 Might Mediate SRF Nuclear Export 
The aforementioned data show that Pk1, Mylk3 and SRF are exported out of the nucleus 
during cardiac chamber formation. Previously, an isoform of Pk1 was reported to facilitate 
nuclear export of a transcriptional regulator (Shimojo and Hersh, 2003; Shimojo and Hersh, 
2006). Another study reported members of the LIM-protein family as both nuclear SRF 
transcriptional cofactors and cytoplasmic scaffold proteins, that shuttle between the two 
compartments during differentiation processes of smooth muscle cells from proepicardial 
cells (Chang et al., 2003). Additionally, previous studies showed that MLCK is required for 
nuclear translocation of NFκB and RelA/p65 (Kimelman and Xu, 2006; Wadgaonkar et al., 
2005) 
It was reported previously that SRF is regulated by changes in nuclear tension (Swift et al., 
2013). Since reduction in both Pk1a and Mylk3 resulted in pMRLC retention in the nucleus, 
local tensions could be affected leading to changes in SRF localization. To that end, SRF 
localization was analyzed in hearts with decreased levels of Pk1a and Mylk3. In hearts with 
reduction in either Pk1a or Mylk3, SRF signal within the nucleus is distinctly stronger than in 
wild-type hearts (Figure 30 A-C). Furthermore, localization of SRF into sarcomeric structures 
is reduced, particularly in mylk3-deficient hearts (Figure 30 C). Thus, both Pk1 and Mylk3 
are involved in regulation of SRF localization. 
 
 
 
Figure 30: Pk1 and Mylk3 are involved in SRF nuclear localization. (A-C) Confocal images of OC myocardium 
at 54 hpf stained for SRF (green) and Alcam (red). (A) In wild type hearts SRF is localized both at sarcomeres 
and in nuclei albeit in lower levels. In a number of cells SRF nuclear localization is not detectable indicating a 
dynamic change in its localization during cardiac remodeling. (B, C) In hearts with decreased levels of pk1a (B) 
or mylk3 (C) the abundance of SRF within nuclei is markedly increased. Scale bar = 10 µm. 
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2.9 PCP Mediates SRF-Regulated Myogenic Differentiation 
2.9.1 Acta2 Expression is Heavily Increased During Cardiogenesis 
Changes in tensional homeostasis accompanied by changes in SRF localization during 
cardiac remodeling are likely to affect SRF-regulated transcription. SRF target genes 
comprise several proteins of the contractile machinery such as smooth muscle, skeletal and 
cardiac α-actin (acta2, acta1b and actc1b), β-myosin heavy chain (β-mhc) and myosin light 
chain 2 (myl2) (Davey et al., 1995; Gustafson and Kedes, 1989; Henderson et al., 1989; 
Molkentin, 1996). Actins are highly conserved among animal species and play crucial roles 
during cell division, migration, cytoskeletal composition, and contraction. Higher eukaryotes 
express six different actins: skeletal, cardiac and smooth muscle α-actins,  
β-actin, γ-actin, and γ-enteric actin (Vandekerckhove and Weber, 1978). While β-actin and 
γ-actin are expressed ubiquitously, smooth muscle actin (acta2) is highly abundant in smooth 
muscle cells, and cardiac α-actin (actc1b) and skeletal α-actin (acta1b) are predominantly 
expressed in striated muscle. During early avian cardiogenesis smooth muscle α-actin is the 
first actin to be strongly expressed in the heart, and precedes following co-expression of 
skeletal and cardiac α-actin (Ruzicka, 1988). In zebrafish, in-situ hybridization revealed that 
apart from acta1b and actc1b, smooth muscle α-actin is also highly expressed in the LHT 
(Thisse et al., 2004).  
To determine the spatiotemporal changes in expression of smooth muscle, skeletal and 
cardiac α-actin during cardiogenesis in zebrafish, cells were sorted for cardiomyocytes and 
non-cardiomyocytes by fluorescence-activated cell sorting (FACS) from Tg(myl7:GFP) line 
labeling all myocardial cells. Subsequently, both populations were analyzed for the 
expression of acta1b, actc1b, and acta2 at LHT stage (26 hpf), shortly after the cardiac 
chambers have formed (54 hpf), in the beginning of trabeculation (72 hpf) and at 120 hpf 
(Figure 31). The data were collected in collaboration with Anne Merks. Fold expressions 
were calculated in relation to 26 hpf stage. During early zebrafish development expression 
levels of acta1b, actc1b, and acta2 change between different stages of cardiogenesis. In the 
GFP-positive cardiomyocytes, acta1b expression increases to 4.7-fold at 54 hpf and then 
drops gradually to 3.3-fold at 72 hpf and 1.7-fold at 120 hpf. Levels of actc1b mRNA increase 
to 8.4-fold at 54 hpf and remain more or less constant with 7.3-fold induction at  
72 hpf and 7.8-fold increase at 120 hpf. In contrast, acta2 mRNA levels are nearly unchanged 
at 54 hpf with a 1.4-fold induction, but expression increases strongly at 72 hpf with an 18-
fold induction and is enhanced further at 120 hpf to 72-fold (Figure 31, cardiomyocytes). In 
the GFP-negative cells mRNA levels of acta1b are increased to 5.2-fold and remain stable 
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until 72 hpf (4.9-fold induction). Expression levels decrease strongly within the next hours to 
1.7-fold. Similarly, levels of actc1b mRNA are increased to 4.2-fold at 54 hpf with a mild 
increase to 5.2-fold at 72 hpf, but are decreased strongly at 120 hpf to a 1.7-fold expression. 
In contrast, mRNA levels of acta2 are increased to 36-fold at 54 hpf and expression is further 
enhanced to 1700-fold at 72 hpf dropping to 1000-fold at 120 hpf (Figure 31, non-
cardiomyocytes). These results suggest, that the different actin isoforms are important during 
different stages of cardiac development. While acta1b and actc1b are more abundant at LHT 
stage and during early cardiac chamber formation, acta2 expression increases mainly after 
the two cardiac chambers have formed. Thus, unlike in other vertebrates, in zebrafish 
myocardial acta2 expression markedly increases only after the two cardiac chambers are 
formed. 
 
 
 
Figure 31: Skeletal, smooth muscle, and cardiac actin are differentially expressed during cardiogenesis. 
In cardiomyocytes expression of skeletal (acta1b) and cardiac actin (actc1b) are increased at 54 and 72 hpf, but 
are downregulated after chamber formation has completed (120 hpf). Smooth muscle actin (acta2) expression in 
myocardial cells is increased by 18-fold at 72 hpf and by 72-fold at 120 hpf. Results of three independent 
experiments. 
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2.9.2 PCP Dysregulation Affects SRF Target Gene Expression 
SRF signal transduction is crucial to proper cardiac development. Several studies show that 
both loss and overexpression of SRF leads to cardiomyopathies and that changes in actin 
distribution in the embryonic heart are associated with impaired development of cardiac 
structure and function (Kumar et al., 1997; Niu et al., 2008; Parlakian et al., 2004). 
To investigate the function of PCP signaling in cardiac-specific SRF/MRTF-A-mediated 
signal transduction, target gene expression was analyzed using quantitative real-time PCR 
in embryos with reduced Vangl2 and Pk1a levels. Reduction in Pk1a results in decrease of 
acta1b levels to 82% and acta2 mRNA levels to 80%, while expression levels of actc1b, tgln 
and srfb are not significantly affected (Figure 32). Furthermore, loss of Pk1a leads to a mild, 
but not significant decrease of pk1b mRNA levels (Figure 32). The control genes ETS 
translocation variant 4 (etv4) and fibroblast growth factor 4 (fgf4) which regulate MRTF-A 
independent cardiac gene expression through SRF (Liang et al., 2001; Znosko et al., 2010), 
were not affected by pk1a knockdown (Figure 32). 
Analysis of SRF target gene expression in vangl2-mutants revealed a decrease in acta1b 
mRNA levels to 70 % and fgf4 levels to 64 % (Figure 33). In contrast to pk1a-deficient 
zebrafish, acta2 expression is increased by 40 % in vangl2-mutants (Figure 33). Expression 
levels of actc1b, tgln, srfb and pk1b are mildly decreased (n.s.) and no effect on etv4 and 
pk1a expression was observed (Figure 33). Taken together, both loss of Pk1a and Vangl2 
result in deficient SRF target gene expression mainly affecting acta1b and acta2 mRNA 
levels. 
 
Figure 32: Pk1 is crucial to SRF signal transduction. Quantitative RT-PCR results in whole zebrafish embryos 
with reduced levels of pk1a at 54hpf. Loss of Pk1a leads to decreased amounts of acta1b and acta2, but not 
actc1b, tgln and srfb. Expression of etv4 and fgf4 is not affected in pk1a-deficient zebrafish. Results of eight 
independent experiments. * = P < 0.05, ** = P < 0.01; t-test. 
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Figure 33: Vangl2 affects myogenic SRF signaling transduction. In vangl2 mutant hearts expression of acta2 
is increased by 40%, while acta1b expression is reduced to 70 % and fgf4 expression decreases to 64 %. Gene 
expression of actc1b, tgln, srfb and pk1b is reduced mildly. Levels of pk1a and etv4 are unchanged. Results of 
three independent experiments. * = P < 0.05, *** = P < 0.001; t-test. 
 
2.9.3 Proper Sarcomerogenesis Requires PCP Signaling 
Cardiac function is dependent on myogenic differentiation and maturation of the heart to 
ensure proper contraction and coupling of the myocardium. During cardiac chamber 
formation sarcomeres start to assemble around 48 hpf, but fully structured sarcomeres are 
not visible by electron microscopy before 96 hpf (Becker et al., 2011; Huang et al., 2009; 
Sehnert and Stainier, 2002). Myofibrils of striated muscle, such as cardiac and skeletal 
muscle, are formed through the assembly of small contractile units, the sarcomeres. 
 
 
 
Figure 34: SRF localizes to Z-discs during cardiac chamber formation. (A) Confocal images of OC 
myocardium at 54 hpf stained for MHC (A’, red in A) and SRF (A’’, green in A). Scale bar = 10 µm. 
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SRF function was shown to be required for sarcomerogenesis in many instances (Balza and 
Misra, 2006; Lahoute et al., 2008; Parlakian et al., 2005). Additionally, regulators of SRF 
signaling were implicated in sarcomere assembly. In zebrafish, loss of Mylk3 resulted in 
failure to form proper sarcomeric structures and overexpression of activated MLCK improved 
sarcomere organization in neonatal rat ventricular myocytes (Aoki et al., 2000; Seguchi et 
al., 2007). Another study showed that ROCK inhibition delayed sarcomere assembly 
(Stepanova et al., 2011). 
First, to address a potential function of SRF during sarcomere assembly, its localization 
within the sarcomeric structures of the early zebrafish myocardium was analyzed in more 
detail. Here, at 54 hpf SRF localizes to Z-discs between M-bands as visualized by myosin 
heavy chain (MHC) (Figure 34). Next, it was addressed whether PCP-mediated changes in 
early actomyosin organization and altered SRF target gene expression result in maturation 
defects. In zebrafish, sarcomere structure assembly is initiated at about 48 hpf (Huang et al., 
2009; Sehnert and Stainier, 2002). Sarcomeric structures in PCP-deficient hearts at  
72 hpf were visualized by MHC staining to ensure potential defects are not due to a delay in 
development. In wild-type hearts myosin-containing thick filaments form highly ordered 
structures that often span several cells (Figure 35 A, A’).  
 
 
Figure 35: Deficient PCP signaling leads to failure in maturation of cardiac muscle.  
(A-D, A’-D’) Confocal images of hearts at 72 hpf stained for myosin heavy chain (MHC), and DAPI in blue (A’-D’). 
(A, A’) Sarcomeres in wild-type cardiomyocytes are highly organized, often forming cables along cell membranes 
spanning several cells. (B-D, B’-D’) In fzd7a-/-, vangl2-/- mutant and pk1a-morphant hearts thick filaments are 
highly disorganized and fail to form intercellular connections. Scale bar = 10 μm. 
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In contrast, sarcomere assembly was severely disturbed in ventricles of fzd7a-/-, vangl2-/- and 
pk1a morphant hearts. Thick filaments were not properly organized, often forming 
filamentous structures or accumulations instead of myosin bundles (Figure 35 B-D, B’-D’). 
Observed defects in sarcomere organization strongly corroborate the hypothesis that PCP 
mediates cardiac maturation through effects on myogenic SRF target gene expression.  
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3 Discussion 
The PCP pathway is known as a master regulator of morphogenesis of a variety of organs. 
Previous studies mainly addressed effects of impaired PCP signaling on gastrulation 
movements and tissue architecture during organ formation of the kidney, eye, and lung 
(Babayeva et al., 2011; Classen et al., 2005; Nagaoka et al., 2014; Ulrich et al., 2005; Zallen, 
2007). Although several studies show the importance of functional PCP signaling during 
heart development by attributing the congenital heart defects to the absence of non-
canonical Wnt ligands or core components of this pathway, its precise role during 
cardiogenesis remains incompletely understood (Henderson and Chaudry, 2011). 
Importantly, formation of the heart requires not only establishment of proper myocardial 
architecture, but also differentiation into a functional syncytium of cardiomyocytes that are 
electrically coupled and able to contract in a coordinative manner. Cardiomyocyte 
differentiation is dependent on myogenic signaling through the SRF transduction cascade. 
Although it has been inferred that PCP might affect SRF signal transduction through its 
downstream effectors such as Rho GTPases, experimental proof for the involvement of the 
PCP core components was not yet brought forward (Hill et al., 1995; Olson and Nordheim, 
2010). The present study reveals a novel function of Wnt non-canonical PCP signaling during 
cardiac remodeling that couples changes in tensional tissue homeostasis to cardiomyocyte 
differentiation regulated by SRF. 
3.1 Mutants Correspond to Morphant Phenotypes 
Recently, biomedical research experienced revolutionary changes in technical 
advancements to target the function of genes through the discovery of CRISPR (Clustered 
regularly interspaced short palindromic repeats) - Cas9 mediated mutagenesis. The 
CRISPR/Cas9 system was discovered first in bacteria and archaea where it provides 
adaptive immunity against invading nucleic acids of viruses and plasmids (Jinek et al., 2012). 
In zebrafish, like in other model systems, it allows fast and efficient generation of knock-out 
models (Bassett et al., 2013; Burger et al., 2016; Gagnon et al., 2014; Lindsay et al., 2016). 
Briefly, during CRISPR-Cas9 mutagenesis short guided RNAs that are homologous to target 
sequences within the genomic DNA facilitate opening of the double stranded structure. 
Secondary structures within the sgRNA allow binding of Cas9 endonuclease, that then 
cleaves 3 nt upstream of a mandatory protospacer adjacent motif (PAM) sequence NGG that 
follows the 20 nt target sequence within the DNA sequence. The PAM sequence is a 2 - 6 
bp DNA sequence targeted by the Cas9 nuclease to facilitate the cleavage. In zebrafish, 
these cleaved sites are mainly repaired via the error-prone process of non-homologous end 
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joining (NHEJ) that frequently induces insertions or deletions (indels) (Sander and Joung, 
2014; Wang et al., 2013). Generation of indels that consist of a number of nucleotides not 
divisible by three leads to a shift of the open reading frame resulting in nonsense mutations 
or a premature stop codon. 
Earlier studies mainly relied on morpholino-induced blockage of translation to investigate 
protein function, since the generation of a full gene knock-out required either time-consuming 
methods like TALEN mutagenesis or discovery of relevant mutations induced by ENU-
mutagenesis in the Sanger Mutation Project (Hwang et al., 2014; Kettleborough et al., 2013). 
With growing availability of mutants, data that were obtained using morpholino knockdown 
technology became the center of attention as several mutant phenotypes reportedly did not 
correspond to those of morphant zebrafish. For instance, in a study that focused mainly on 
vascular morphogenesis, only about 20% of morphant phenotypes were also observed in 
mutant embryos (Kok et al., 2015). However, few studies of morphant knockdown technology 
showed reliability, albeit with observed differences between morphant and mutants 
phenotypes. For instance, egfl7 mutants did not display vascular phenotypes that were 
observed in egfl7 morphant fish. However, detailed analysis of both mutants and morphants 
revealed that complete loss of egfl7 was compensated by increase in Emilin2/Emilin3 that 
was not induced in egfl7 morphant zebrafish and that overexpression of Emilin 2 partially 
rescued morphant phenotypes (Rossi et al., 2015). 
In the present study initial analysis of phenotypic effects on zebrafish cardiac development 
after PCP pathway disruption was carried out using morpholino knockdown technology. 
Later, additional data were obtained by analyzing mutant and CRISPant phenotypes. Here, 
CRISPants (CRISPR-mediated somatic mutants) were generated by injection of 
CRISPR/Cas9 protein complexes, which yields up to 100% efficiency of transient 
mutagenesis of target genes and can be used for immediate phenotypic screening 
(Supplement Figure 37) (Burger et al., 2016; Lindsay et al., 2016; Shah et al., 2015). Off-
target and toxic effects were minimized by identification of threshold levels through dose-
response curves in both zebrafish morphants and CRISPants. Importantly, quantification of 
transitory states during cardiac remodeling as well as imaging of SRF localization and 
sarcomere organization was highly reproducible when comparing vangl2, fzd7a, and pk1a 
morphants with vangl2, fzd7a mutants and pk1a CRISPants. For this reason, the analysis of 
mutant, morphant or CRISPant phenotypes was used interchangeably. However, it is 
important to take into account that variability is increased in CRISPants and most consistent 
results are achieved in stable mutants such as the vangl2m209 mutant.  
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3.2 PCP-Dependent Epithelial Remodeling Guides Cardiac 
Chamber Formation 
During vertebrate cardiogenesis the chambered and looped heart is formed from a simple 
linear tube through a process that to date is termed cardiac ballooning (van den Berg and 
Moorman, 2009). While specification of cardiac precursors, migration patterns of cardiac 
progenitors to the ventral midline and the formation of the LHT have been studied 
extensively, the understanding of subsequent processes that underlie cardiac looping and 
chamber formation remains limited (Staudt and Stainier, 2012). 
3.2.1 PCP Drives Myocardial Remodeling through Regulation of 
Cell Rearrangements 
One of the first obvious changes in tissue architecture during cardiac chamber formation is 
the emergence of region-specific differences in cardiomyocyte size and shape within the IC 
and OC of the ventricle. Differences in outer and inner curvature regions have been 
described previously (Auman et al., 2007; Panáková et al., 2010). This study verifies the 
previous results, albeit the circularity values of both, outer and inner curvature 
cardiomyocytes, slightly deviate from those reported. This is very likely due to the increased 
accuracy achieved by the software-based definition of cell outlines labeled with anti-Alcam 
stainings and quantification of all cells within the respective regions. 
These region-specific differences in tissue architecture, but more importantly the expansion 
of the cardiac chambers are achieved via cell rearrangements. The initial evidence was 
brought forward from in vivo time-lapse imaging of the LHT myocardium, in which formation 
of rosettes and their subsequent resolution was observed. This finding strongly suggests that 
mechanisms of epithelial remodeling, that were shown to be crucial for organogenesis of 
several organs, also underlie cardiac chamber formation. However, live imaging of epithelial 
remodeling in cardiac tissue could only be performed in non-contractile hearts of tnnt2-
morphant embryos, since spatial-temporal resolution was limited in beating hearts using the 
methods at hand. Actomyosin modulation is pivotal to mechanisms that guide cell 
rearrangements. For instance, previous studies have shown that MRLC phospho-variants 
can influence number, speed, and nature of cell rearrangements (Kasza et al., 2014). Since 
in the absence of tnnt2 actomyosin contraction is impaired, it is likely that the observed time-
span of 5 hours of rosette resolution does not completely reflect the timing of this process. 
However, recently developed methods that utilize high-speed selective plane illumination 
microscopy (SPIM) together with brief interruption of the heart beat using optogenetics will 
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allow for high resolution reconstructions as well as shed more light on the dynamics of 
processes that underlie cardiac remodeling (Mickoleit et al., 2014). 
It was previously proposed that the number of points in which four or more cells converge 
into a central junction reflects the activity of a single-layered tissue undergoing remodeling 
via cellular rearrangements (Blankenship et al., 2006; Farhadifar et al., 2007; Villasenor et 
al., 2010). The LHT myocardium features a high number of transitory states, which indicate 
the presence of intercalating cells within the myocardial cell layer. The number of rosettes 
and T1-transitions decreases significantly within the following 24 h until the two cardiac 
chambers form suggesting that early cardiac remodeling is driven by cell rearrangements at 
LHT stage. As PCP signaling drives epithelial remodeling in many instances, its potential 
role in directing cell rearrangements within the early myocardium was tested. Indeed, in loss-
of-function studies using morpholino knockdown, CRISPants and PCP-mutants, 
dysregulation of PCP signaling results in altered number of transitory states at 54 hpf. Here, 
Wnt11 and Wnt5b are main regulators of myocardial remodeling. Down-regulation of either 
Wnt5b or Wnt11 results in a mild increase of transitory states. However, simultaneous 
knockdown of Wnt5b and Wnt11 led to an increase of transitory states suggesting that they 
function synergistically to regulate cardiomyocyte rearrangement. This observation is 
supported by a study that shows that complexes between Wnt11 homodimers and Wnt5a 
homodimers are required for Xenopus axis formation (Cha et al., 2008). 
Decrease in Fzd7a, Dvl2, and Pk1a levels results in an increase in transitory states, while 
down-regulation of Vangl2 leads to mild reduction in transitory states. The number of 
transitory states in absence of Fzd7a is comparable to that observed in Wnt5b/Wnt11 
morphants indicating that Fzd7a is the main receptor mediating the non-canonical Wnt 
signaling. However, whether the observed increase transitory states caused by down-
regulation of Fzd7a or Wnt11 and Wnt5b are due to their more frequent formation or because 
they fail to resolve can only be determined by live imaging and tracking of fluorescently 
labeled cells. Furthermore, it remains to be determined whether transitory states resolve 
stochastically or asymmetrically, and thus shape the cardiac chambers’ axes. Whether PCP 
signaling could play a role in such a polarized mechanism remains to be determined.  
3.2.2 PCP Establishes Regionally Restricted Cardiomyocyte 
Characteristics 
Previous studies have not addressed regional differences in cardiomyocyte orientation, 
although cardiomyocyte elongation in accordance with the stretching direction seems to be 
prerequisite for the normal function of these cells (Wang et al., 2014). This study describes 
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myocardial architecture in more detail by analyzing cardiomyocyte orientation in regard to IC 
and OC position. During cardiac chamber formation elongation and alignment of 
cardiomyocytes along the curvatures is crucial for establishing the overall shape of the 
ventricle. Here, especially positioning of OC cardiomyocytes in a radial pattern defines 
distinct ventricular shape. Thus, investigation of cardiomyocyte shape and organization 
within specified regions of the ventricle allows assessment of the effects of impaired PCP 
signaling on ventricular shape. This study shows that PCP signaling is indispensable for cell 
orientation within the ventricular chamber. Specifically, disruption of PCP signaling leads to 
defects in cardiomyocyte positioning in OFT regions. This finding underlines the importance 
of PCP during OFT remodeling in accordance with several other studies that found that 
CHDs related to mutations of PCP core components usually result in OFT region defects 
(Hamblet, 2002; Henderson and Chaudhry, 2011; Henderson et al., 2001; Phillips, 2005; 
Schleiffarth et al., 2007; Wu et al., 2011). Taken together, the data presented in this study 
indicate that failure to establish typical ventricular shape and remodel OFT may be due to 
impaired cell rearrangements regulated by PCP signaling. 
3.2.3 Fzd7a and Vangl2 Function Determines FHF/SHF Contribution 
Several studies in the recent years have proven the existence of a SHF in the zebrafish heart 
despite only primitive OFT region and the absence of a right ventricle, which are the main 
compartments of the heart formed through addition of SHF cardiomyocytes in higher 
vertebrates. In zebrafish, the primitive LHT arises from cardiomyocytes of the FHF, and a 
second population of cells from the SHF contributes to the formation of the myocardium of 
the arterial and venous poles (de Pater et al., 2009; Hami et al., 2011; Mosimann et al., 
2015). 
The data obtained in this study suggest that core components of the PCP pathway control 
mechanisms that regulate the pool of undifferentiated cardiac precursors of the FHF or SHF. 
Specifically, the myocardium of hearts with decreased levels of the Wnt receptor Fzd7a 
consists of a higher proportion of FHF derived cardiomyocytes, while Vangl2 deficient hearts 
show larger portions of cells that are presumably of SHF origin. However, whether Wnt/PCP 
signaling targets cardiac precursor proliferation, their differentiation or migration remains to 
be answered. 
Previous studies were able to show that expansion and allocation of early heart progenitors 
is dependent on Wnt/β-Catenin signaling, since genetic activation of the pathway using a 
stabilized form of β-Catenin resulted in marked proliferation of SHF progenitors (Ai et al., 
2007; Kwon et al., 2007). Potential downstream targets of β-Catenin comprise isl1 and fgf10 
suggesting a link between Wnt and FGF signaling pathways in SHF specification (Lin et al., 
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2007; Luo et al., 2015). Elevated FGF8 signaling with downstream targets such as FGF4 
(Sun et al., 1999), has been associated with excessive proliferation of secondary heart field 
progenitors and failure of the myocardial cells to be added to the heart (Waldo et al., 2005). 
If FGF8 induced FGF4 expression in cardiac progenitors, observed reduction in fgf4 mRNA 
expression levels in the absence of Vangl2 were in disagreement with increased number of 
SHF derived cardiomyocytes when Vangl2 is missing. Moreover, a recent study shows that 
loss of Vangl2 results in SHF progenitor reduction and premature differentiation in the distal 
outflow tract (Ramsbottom et al., 2014). The contrasting results presented in this study with 
those reported previously demonstrate that more detailed studies are required to address 
the spatial as well as temporal requirement of PCP signaling during FHF/SHF specification. 
In addition, the defects in cardiac looping together with decreased SHF cell number in fzd7a-
deficient hearts suggests that PCP might be involved in regulating cardiac looping through 
changes in SHF migration. To that end, cell-tracing experiments could be performed to follow 
migration of cardiomyocytes in PCP-deficient hearts to confirm defective addition of SHF 
cardiomyocytes into the developing heart. Altogether, the results indicate a putative role of 
the PCP core components in cardiac precursor proliferation, specification or migration. 
However, future studies should address what cellular process is targeted by non-canonical 
PCP signaling. 
3.3 PCP Targets Tensional Homeostasis by Regulation of 
Actomyosin Contractility 
Cell intercalation in single-layered tissues is driven either through remodeling of cadherin 
rich adherens junction or protrusion formation similar to filopodia in migratory cells (Walck-
Shannon and Hardin, 2013). Thus, I next elucidated the mechanism that underlies the 
regulation of cell rearrangements through PCP signaling in the heart. Since loss of Fzd7a 
and Vangl2 led to opposing effects on the amount of transitory states within the myocardium 
at 54 hpf, I focused on analyzing junctional integrity and actomyosin organization in the 
hearts with decreased levels of Fzd7a or Vangl2.  
3.3.1 PCP Signaling Does Not Affect N-Cadherin Localization 
Cells need to be mechanically coupled in order to transmit force effectively. Cadherins at the 
cell-cell contacts mediate the mechanical linkage and through modulation of F-actin regulate 
tissue stiffness and tissue surface tension (Gumbiner, 2005). Cadherin-mediated cell 
adhesion and signal transduction is pivotal during cardiomyogenesis and cardiac disease 
(Piven et al., 2011; Resink et al., 2009). Several studies showed direct control of N-Cadherin 
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through Wnt non-canonical signaling components in diverse contexts (Nagaoka et al., 2014; 
Tufan et al., 2002). 
In the ventricular myocardium of fzd7a or vangl2 morphant hearts no change in N-cadherin 
localization or abundance was detected at 54 hpf. However, it cannot be excluded that 
dysregulation of the PCP pathway has an effect on rate of N-cadherin endosomal recycling 
as the regulation of cell rearrangements could be regulated by cadherin turnover rates in a 
number of instances (Bentley et al., 2014; Classen et al., 2005; Ulrich and Heisenberg, 
2008). Additionally, it was shown that conformational change of cadherins at cellular 
junctions affects their stability resulting in changes of the strength of adhesive bonds between 
cells (Hong et al., 2011). It remains to be addressed if cadherin mobility or stability at cellular 
junctions has an impact on cell rearrangements through changes in cell adhesion. Besides 
cadherin dynamics, changes in intercellular adhesion are mediated via availability of Ca2+ 
(Takeichi et al., 1981). Thus, the PCP pathway could act on adhesion processes through 
effects on intercellular as well as intracellular Ca2+ concentrations. 
3.3.2 PCP Signaling Organizes Polarized Actomyosin  
It is well known that cell shape changes are driven by actomyosin-induced contractions to 
establish new tissue morphologies. PCP signaling is indispensable for organization of 
cytoskeletal components in all cells (Tada and Kai, 2009). Transient expression of a 
membrane-associated form of EGFP in morphant hearts revealed that reduction in Fzd7a 
levels results in increased formation of basal protrusions and apical constriction. Cellular 
protrusion formation is crucial for oriented cell migration. Hence, it is likely that cardiomyocyte 
migration is affected in hearts with reduced levels of Fzd7a. The fact that ventricles of fzd7a 
deficient hearts might incorporate fewer SHF cardiomyocytes could support this claim. 
Additionally, recent concepts evolve around the function of Wnt intercellular signaling through 
basal cytoplasmic projections (Stanganello and Scholpp, 2016); one of the studies shows a 
central function of Fzd7 during signaling between ectodermal and somatic epithelia (Sagar 
et al., 2015). Given that Wnt11 is expressed in the pharyngeal mesoderm, in a tissue 
juxtaposed to the heart tube’s arterial pole, and has to instruct the ventricular cells several 
cell diameters away, Fzd7 regulated basal cell protrusions could facilitate the 
communications between Wnt11 producing and receiving cells. 
Proper formation of the apical actomyosin network is specified by correct establishment of 
the apical domain, and regulated by apicobasal polarized proteins like Par6 and Par3 and 
aPKC (Putzke and Rothman, 2003; Sawyer et al., 2010). PCP is known to establish 
apicobasal polarity, for instance through binding of Dvl to aPKC. (Zhang et al., 2007). 
Through this mechanism, PCP mediates the formation of contractile actomyosin at the cell 
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cortex at apical tight junctions. Actomyosin structures within fzd7a deficient cardiomyocytes 
show irregular protrusive patterns that are enriched at the basolateral compartment of 
cardiomyocytes. This finding strongly suggest that PCP signaling is crucial to establish and 
maintain polarized actomyosin structures in the developing vertebrate heart. 
 
3.3.3 PCP Controls Spatially Restricted Myosin Regulatory Light 
Chain Contractility 
In heart, coordinated contractility by actomyosins is fundamental for its proper function and 
encompasses not only tight regulation of cardiac myosins, but also non-muscle myosins 
(Vicente-Manzanares et al., 2009). Non-muscle myosin II (NMII), a member of the myosin II 
subfamily that includes cardiac, skeletal, and smooth muscle myosin, was shown to be the 
key regulator of cell intercalation movements. The protein is enriched at disassembling cell-
cell junctions and becomes localized to temporary junctions and rosettes, where it appears 
to drive the formation of new junctions by preventing reversion to the original cell orientation 
(Bertet et al., 2004; Zallen and Wieschaus, 2004). NMII localization or activity is regulated 
by phosphorylation and dephosphorylation of its regulatory light chain (pMRLC) involving a 
tightly regulated interplay between ROCK, MLCK, and myosin phosphatase (MYPT) activity 
(Matsumura et al., 2001; Riento and Ridley, 2003). 
This study provides evidence for a novel role of coordinated activity of NMII regulatory light 
chain (MRLC) during cardiac chamber formation through rapid relocalization of pMRLC from 
the nucleus to the cell junctions between 26 and 28 hpf. At 24 hpf pMRLC is localized 
predominantly in the nucleus of ventricular cardiomyocytes. However, at 54 hpf, after the 
cardiac chambers have formed, pMRLC is no longer present in the nuclei, but localizes to 
actomyosin fibers within the cytoplasm and at the vicinity of plasma membrane. Here, a 
distinct accumulation of pMRLC to points of active cell rearrangements suggests its role in 
epithelial remodeling during cardiac chamber formation. The importance of this relocalization 
seems to be specific to active MRLC, since its unphosphorylated form exclusively localizes 
to cell membranes and is never present in the nuclear compartment. During body axis 
elongation in Drosophila, unphosphorylated MRLC resulted in fewer, slower cell 
rearrangements, while phosphomimetic MRLC accelerated cell rearrangements and 
incorporated more cells into rosette structures (Kasza et al., 2014). Further studies should 
aim at a deeper understanding of the role of MRLC phosphorylation during cardiac chamber 
formation by investigating the effects of overexpression of MRLC variants that prevent or 
mimic phosphorylation on transitory states as well as ventricular shape. 
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The antibody used to detect the phosphorylated and non-phosphorylated form of MRLC is 
specific to myosin regulatory light chain 12b and 9b. Results acquired by using the antibody 
against the phosphorylated form of MRLC could not be reproduced after acquiring another 
antibody batch for which processes during its production were modified by the manufacturer. 
However, in immunostainings with this antibody batch decreased signal of pMRLC after 
treatment with the ROCK inhibitor Y27623 indicates that the signal is specific to MRLC 
phosphorylation and that results acquired using this antibody batch allow for meaningful 
interpretation. 
Wnt non-canonical signaling was implicated in mechanisms that differentially regulate 
myosin II-based contractile forces in various contexts mainly through downstream effectors 
of PCP signaling such as ROCK or aPKC (Blankenship et al., 2006; Lee et al., 2012). 
Recently, it was shown in Ciona intestinalis that MRLC co-localizes with the PCP core protein 
Vangl and Pk (Newman-Smith et al., 2015). Thus, the PCP pathway likely targets either NMII 
localization or its activity in the developing heart and during cardiac chamber formation in 
particular. Indeed, in loss of function studies, defective PCP signaling results in altered 
pMRLC localization and abundance at 26 hpf. Here, reduction in Fzd7a and Dvl2 leads to 
decreased levels of pMRLC, which is likely caused by effects of defective Wnt non-canonical 
signaling on MRLC phosphorylation through ROCK (Strutt et al., 1997). In contrast, 
knockdown of Vangl2 or Pk1a results in changes in pMRLC localization. Here, pMRLC 
relocalizes to cell membranes more rapidly in hearts with reduced levels of vangl2, whereas 
pMRLC nuclear localization is increased in pk1a morphant hearts. However, it remains 
uncertain, if PCP targets pMRLC localization, transport or spatially restricted phosphorylation 
of MRLC. 
Translocation of pMRLC from the nucleus to the cell membrane likely affects tensional 
homeostasis within the early zebrafish myocardium. Phosphorylation of MRLC was 
repeatedly shown to affect localized tension (Cai et al., 2006; Lecuit et al., 2011). Nuclear 
tension was determined through analysis of solidity at 24 hpf and 30 hpf. Here, high nuclear 
tension corresponds to high abundance of both pMRLC and G-actin in the nucleus at early 
LHT stage, while reduction in these proteins responds to decreased tension in the nuclear 
compartment. With initiation of cardiac chamber formation at around 30 hpf, pMRLC localizes 
to cell junctions. Several studies confirm a role of MRLC during epithelial remodeling through 
accumulation at central junctions of cell clusters during cell rearrangements (Blankenship et 
al., 2006; Zallen and Blankenship, 2008). 
Actin dynamics within the nucleus were shown before to regulate myogenic SRF target gene 
expression through changes in MAL/MRTF-A localization (Baarlink et al., 2013; Vartiainen 
et al., 2007). Crm1-mediated export of MRTF-A is dependent on binding of G-actin to MRTF-
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A, and nuclear actin prevents SRF activation (Olson and Nordheim, 2010; Vartiainen et al., 
2007). Here, G-actin levels are regulated by F-actin formation in the cytoplasm, for example 
due to RhoA-induced stress fiber formation (Lundquist et al., 2014; Vartiainen et al., 2007). 
This underlines the potential significance of G-actin translocation from the nucleus to 
filamentous structures during early cardiac development. Additionally, MRLC was suggested 
to act as a core transcription factor that is regulated by control of its phosphorylation status, 
which in turn coordinates relative motion between DNA bound to myosin II and RNA 
polymerase II bound to actins and nucleoskeleton (Li and Sarna, 2009). In future studies, the 
role of MRLC or pMRLC during cardiac gene expression should be explored. 
3.3.4 MRLC Phosphorylation is Spatially Regulated by Mylk3 
Activity of MRLC is controlled by interaction between ROCK, MLCK, and the myosin 
phosphatase (MYPT), that regulate its phosphorylation and dephosphorylation status in a 
complex interaction network. Briefly, ROCK and MLCK directly phosphorylate MRLC, while 
MYPT reduces MRLC phosphorylation (Loirand, 2006). Expectedly, inhibition of Rock using 
Y27623 decreases the amount of MRLC phosphorylation in zebrafish hearts. On the other 
hand, inhibition of Mylk3, the cardiac isoform of MLCK in zebrafish, using morpholino 
knockdown resulted in restricted localization of pMRLC within the nucleus. This finding 
suggests a role of this kinase in spatially controlled phosphorylation or in mechanisms 
controlling its translocation. Spatially restricted phosphorylation by ROCK and MLCK was 
observed in 3T3 fibroblasts (Totsukawa et al., 2000). Here, Rock was shown to inhibit MYPT 
and phosphorylate MRLC directly at the center of the cells, while MLCK activity induced 
phosphorylation of MRLC at the cell periphery. As a result, induction of peripheral pMRLC 
induced fibroblast migration (Totsukawa et al., 2004). Further studies should address 
whether Mylk3 targets spatially restricted phosphorylation or pMRLC transport from the 
nucleus. 
MLCK is activated in response to Ca2+ release from intracellular stores. In both skeletal and 
cardiac myocytes binding of Ca2+ to Calmodulin induces MLCK to phosphorylate MRLC on 
serine 19. This in turn increases the contractile strength of actomyosin. Since PCP is known 
to affect Ca2+ release from intracellular stores and actomyosin contractility, its effect on 
MLCK activity through Calmodulin is likely. Hence, nuclear pMRLC in both mylk3- and pk1a-
deficient hearts further enforces a role of PCP signaling in spatially restricted phosphorylation 
of MRLC as a downstream effector. Further studies should address whether loss of Pk1 and 
Mylk3 in fact increases nuclear tension and whether Pk1a acts upstream of Mylk3 activity. 
Future studies should aim at understanding the role of Pk1 within the complex network of 
pMRLC regulation. Phosphorylation of MRLC involves tight regulation of various processes 
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not only dependent on various kinases, but also on the phosphatase MYPT1 and Ca2+ 
signaling (Riento and Ridley, 2003). For instance, ROCK not only increases MRLC 
phosphorylation directly, but also indirectly through phosphorylation of MYPT1, which inhibits 
its phosphatase activity, and results in elevated pMRLC levels (Somlyo and Somlyo, 2004). 
Interestingly, MYPT1 translocation was implicated in regulation of cardiac differentiation of 
mouse embryonic stem cells, where MYPT1 was shown to function as a nuclear exporter of 
Nkx2.5 (Ryan et al., 2013). Loss of function studies targeting MYPT1 should explore potential 
effects on nuclear translocation of pMRLC and SRF signal transduction to determine whether 
the phosphatase acts downstream of PCP signaling. Furthermore, Wnt non-canonical 
signaling is known to act upstream of Calmodulin through its effects on Ca2+. Calmodulin is 
activated after binding of Ca2+, which leads to increased interaction and activation of several 
kinases and phosphatases (Kühl et al., 2000; Kühl et al., 2001; Sheldahl et al., 2003; Shimizu 
et al., 2006). 
3.4 PCP Signaling Acts Upstream of SRF Signal Transduction 
Wnt non-canonical signaling fulfils many functions during heart development. Among other 
things, this study shows that it targets actomyosin localization during embryonic cardiac 
remodeling. In general, PCP-mediated effects on actomyosin are well described; mostly 
through studies on its role in regulation of Rho signal transduction and Ca2+ release from 
intracellular stores. This study describes a novel role of this pathway that involves regulation 
of mechanisms within the nuclear compartment that are crucial to myogenic differentiation. 
3.4.1 Nuclear-Specific Processes During Cardiac Development 
Require Pk1 Function 
Whereas various functions of the PCP signaling core components Fzd7, Dvl2 and Vangl2 
have been described, less is known about the function of Pk1. For instance its involvement 
in control of the directionality of tissue polarity during Drosophila wing or vertebrate limb 
growth has been addressed only recently (Sharp and Axelrod, 2016; Yang et al., 2013). In 
this study, it was revealed that Pk1 localizes to the nuclei of cardiomyocytes of the developing 
zebrafish myocardium as well as to those of H9c2 cells. The role of Pk1 in the nucleus is not 
very well understood. Shimojo and Hersh suggested that Pk1 could act as a nuclear receptor 
which is involved in nuclear trafficking of the transcription repressors REST/NRSF and 
REST4 (Shimojo and Hersh, 2006). Additionally, it was shown that its nuclear localization is 
required for facial branchiomotor neuron migration (Mapp et al., 2010). As reduction in Pk1a 
results in increased nuclear localization of both pMRLC and SRF, Pk1 might play a role 
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during nuclear transport mechanisms of these factors. Nuclear localization of Pk1 depends 
not only on its nuclear localization signals (NLS), but also on a farnesylation motif in the C-
terminal part of the protein (Mapp et al., 2010). To confirm a nuclear function of Pk1, further 
studies should assess whether inhibition of Pk1 translocation through deletion of its NLS and 
farnesylation motifs leads to effects on SRF and pMRLC localization similar to those 
observed in hearts with complete loss of the protein. In contrast to a potential function of Pk1 
as shuttle protein, SRF translocation might be mediated indirectly through changes in nuclear 
tension after pMRLC export, decrease in nuclear kinase activity or localized actomyosin 
contractility in the course of myocardial maturation. Future studies should aim at elucidating 
the role of Pk1 in tensional homeostasis and its effects on SRF translocation. 
Apart from spatially regulated effects on tension, kinase activity and actomyosin contractility, 
Pk1 itself could act either as a transcriptional co-activator of SRF, similar to MRTF-A or it 
could regulate the SRF co-factor switching. In pk1a morphants SRF remains longer within 
the nucleus, however, its target gene expression is reduced. Previous studies show, that 
SRF signal transduction is not only controlled by nuclear localization, but also by cofactor 
association. SRF-DNA complexes are bound by at least two different co-factors – MRTF and 
TCF (Posern and Treisman, 2006). Strong evidence for regulated SRF cofactor exchange 
was provided in vivo, where smooth muscle differentiation was reduced by platelet-derived 
growth factor (PDGF) induced ERK signaling. This exchange was initiated by phosphorylated 
Elk-1 that switched places with Myocardin at SRF target promoters, such as tgln (Wang et 
al., 2004). Elk-1 phosphorylation is regulated by phosphorylated JNK, a known target of PCP 
signaling (Pellicer, 1998). Thus, Pk1 could facilitate the binding of a distinct co-factor to SRF 
indirectly via downstream PCP targets. Alternatively, Pk1a itself might act as a cofactor for 
SRF as it was shown for the LIM-only proteins CRP1 and CRP2, that both associate with 
SRF and GATA4 and bind to actin structures within the nucleus to control smooth muscle 
differentiation (Chang et al., 2003). Other LIM-domain containing proteins were shown to act 
on SRF signal transduction through changes in actin dynamics. Limk1, for instance, is able 
to activate SRF through its ability to regulate actin treadmilling (Sotiropoulos et al., 1999). 
However, another member of the LIM protein family, four-and-a-half LIM domain 1 (Fhl1) 
was shown to be crucial to induce myogenesis in mouse C2C12 myoblasts by binding to 
TCF/LEF (Lee et al., 2012). Thus, in the context of early cardiogenesis it remains unclear if 
and how SRF is differentially controlled in regard to MRTF / TCF co-factor binding. For this 
reason, both proposed roles of Pk1 in modulating SRF signaling should be explored in future 
investigations.  
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3.4.2 Changes in Cellular Tension are Coupled to SRF-Mediated 
Cardiac Maturation 
Tight regulation of SRF target gene expression is crucial for proper sarcomere assembly and 
cardiac contractile function. Whereas SRF function as nuclear regulator has been described 
since decades, its function within the cytosolic fraction of skeletal myocytes remains elusive 
(Flück et al., 1999; Rech et al., 1994). Although most components of sarcomeres are known, 
it remains poorly understood how is the assembly and patterning of sarcomeric protein 
complexes regulated. 
From the studies of avian sarcomere assembly, both smooth (Acta2) and skeletal α-actin 
(Acta1b) localize to developing sarcomeres. During early development overall expression of 
smooth muscle actin decreases with regionalized accumulation in inflow and outflow tract 
regions, while skeletal α-actin expression remains high over the whole ventricle (Ruzicka, 
1988; Sugi and Lough, 2005). Thus, both smooth muscle and skeletal α-actins are involved 
in sarcomere assembly with a specific role of smooth muscle actin during early 
sarcomerogenesis. Interestingly, expression levels of actin isoforms in zebrafish 
cardiomyocytes during early cardiogenesis seem to variate from those observed in mouse 
cardiomyocytes. Here, acta2 is expressed in high amounts right after differentiation into 
cardiomyocytes at E9.5 and drops at E17, while expression of acta1b increases at E13 and 
is reduced only after 2 weeks. All this time, actc1b mRNA remains at a high expression level 
(Clement et al., 2007). 
Sarcomere assembly leads to increased tension within the myocardium; a process that might 
be inducing SRF translocation from the nucleus. During cardiac development several 
mechanical forces are exerted on the tissue. Firstly, blood flow generates frictional force on 
the surface of the myocardium. This process was shown to be essential during cell fate 
specification of cardiomyocytes (Huang et al., 2010). Secondly, stretching of cardiac 
chambers activates transcription factors such as GATA4 (Hautala et al., 2002; Hautala et al., 
2001). Effects of PCP-mediated changes in tensional homeostasis on SRF target gene 
expression should be investigated further to elucidate the importance of force during cardiac 
tissue morphogenesis in more depth. 
In zebrafish hearts, SRF is highly abundant in the nucleus at LHT stage and translocates to 
sarcomeric structures between 52 and 58 hpf. This correlates with the onset of increased 
acta2 expression and decreased acta1b expression. Reduction in pk1a results in decreased 
levels of both acta1b and acta2. In contrast, loss of Vangl2 leads to decreased levels of 
acta1b, but induces acta2 expression. In both vangl2-and pk1a-deficient hearts no change 
in expression of two other SRF target genes, actc1b and tgln, was observed. Formation of a 
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complex between Pk1 and Vangl2 is crucial to functional Wnt signaling (Jenny, 2003). It is 
possible, that loss of Vangl2 releases now unbound Pk1a that in turn is capable to prolong 
SRF-mediated acta2-expression. To verify this, knockdown of both pk1a and vangl2 using 
subthreshold levels of morpholino should be performed to investigate their potential 
interaction. Taken together, these data suggest that tightly regulated acta2-expression 
seems to be pivotal to cardiac maturation. During avian cardiogenesis Acta2 was reported 
to be spatially restricted to OFT regions early after cardiac chamber formation (Ruzicka, 
1988; Sugi and Lough, 2005). In line with these reports, OFT defects observed in PCP-
deficient zebrafish hearts could correspond to changes in acta2 expression levels. 
Additionally, acta1b and actc1b share significant sequence homology that allows either one 
of them to at least partially rescue loss-of-function of the other (Kumar et al., 1997; Nowak 
et al., 2009). 
Earlier studies showed that cardiomyocyte differentiation is dependent on Dkk/Wnt11 activity 
(Tzahor, 2007). Loss of Vangl2, Pk1a and Fzd7 results in disturbed sarcomere formation that 
was visualized by staining for cardiac MHC. Thus, functional PCP signaling is pivotal for 
cardiomyocyte differentiation and cardiac maturation. In particular, SRF-mediated cardiac 
maturation is likely dependent on downstream effectors of PCP-signaling. In 2007, Seguchi 
et al. reported that sarcomere assembly in the zebrafish heart is regulated by a cardiac 
specific myosin light chain kinase (cMLCK). In this context, decreased phosphorylation of 
MRLC inhibited epinephrine-induced activation of sarcomere reassembly (Seguchi et al., 
2007). Since Mylk3 reduction leads to increased SRF abundance in nuclei of hearts at 54 
hpf, a potential role of this kinase during cardiac maturation should be investigated in further 
studies. Thus, the mechanisms underlying PCP-mediated cardiac maturation remain to be 
elucidated. 
3.5 Conclusion and Outlook 
This study provides evidence that early cardiac remodeling and maturation of the zebrafish 
myocardium is mediated heavily by activation of the non-canonical Wnt/PCP pathway 
through Wnt11/Fzd7a. Specifically, PCP signaling guides cardiac chamber formation through 
effects on cell rearrangements mediated mainly through Fzd7a and Wnt11/Wnt5b. Cardiac 
remodeling through Wnt non-canonical signaling ensures formation of proper myocardial 
tissue architecture of the ventricular chamber and looping of the heart. Additionally, cardiac 
shape is established by control of SHF contribution through Fzd7a. On a cellular level, PCP 
affects cardiomyocyte shape through effects on actomyosin. A novel function of Wnt non-
canonical signaling was identified for pMRLC localization during early phases of cardiac 
chamber formation. Notably, both Vangl2 and Pk1a take roles in translocation of pMRLC 
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from the nucleus to cell junctions at LHT stage. Translocation of pMRLC and G-actin from 
nucleus to cell junctions is accompanied by changes in nuclear tension and LMNA 
localization. SRF signal transduction, a process responsive to changes in tensional 
homeostasis, is affected in hearts with deficient PCP signaling (Figure 36). The presented 
findings reveal a novel function of the PCP-specific core components Vangl2 and Pk1a in 
modulation of SRF-mediated myogenic gene expression. Dysregulation of PCP signaling 
results in defective cardiac maturation and sarcomerogenesis. Collectively, these data 
support the concept that the Wnt non-canonical pathway couples changes in actomyosin 
tension with myocyte differentiation during cardiac chamber formation through effects on 
SRF signaling. 
Interaction of PCP core components has been described extensively. Thus, future studies 
should aim at understanding the distinct roles of PCP core components of this complex 
network during cardiogenesis. For instance, Prickle and Vangl2 have been shown to interact 
both biochemically and genetically (Jenny, 2003). Decreased levels of pk1 result in reduction 
in wnt5b and vangl2 (Yang et al., 2013). Myosin II is involved of feedback regulation of Vangl2 
polarity (Ossipova et al., 2015). Further investigation should explore possible feedback loops 
between Vangl2, Pk1 and MRLC which control myocardial differentiation. Double knockdown 
experiments could aim at understanding whether one of these proteins acts upstream of the 
other. Wnt non-canonical signaling not only affects cytoskeletal structures, but also Ca2+ 
dependent signal transduction. Effects on SRF signaling through the Ca2+/calmodulin-
dependent kinase (CaMK) have been reported previously and should be explored as 
potential target of Wnt non-canonical signaling (McKinsey, 2007). 
Further studies should aim at a broader understanding of the function of forces in the context 
of transcriptional regulation during organ development. To this end, tension sensors can be 
utilized to visualize mechanical forces that act on specific molecules involved in force 
transduction and also transcriptional regulation (Grashoff et al., 2010). Lastly, apart from 
proteins of the contractile apparatus, SRF also targets non-contractile proteins involved in 
cardiac function such as the sarcoplasmic reticulum Ca2+-ATPase (SERCA) and the 
Na+/Ca2+ exchanger Ncx1 (Argentin et al., 1994; Cheng et al., 1999). Previous data show 
changes in velocity of action potential propagation in vangl2 mutants and pk1a morphant 
zebrafish hearts (Panáková et al., 2010). Thus, it will be interesting to explore the role of SRF 
during the formation of proper electrical coupling across the developing ventricular 
myocardium. 
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Figure 36: Model of SRF signal transduction regulated by PCP signaling. At LHT stage (24 hpf) nuclear 
tension is high due to accumulation of proteins of the contractile machinery such as pMRLC and G-actin. At the 
same time Pk1a and SRF are highly abundant in the nucleus. With onset of cardiac chamber formation (30 hpf) 
pMRLC localizes to central junctions of cell clusters to facilitate cell rearrangements. This process requires tight 
regulation of PCP signal transduction. During cardiac chamber formation, tensional tissue homeostasis is altered 
due to changes in actomyosin localization resulting in partial SRF translocation and modified myogenic gene 
expression. Simultaneously, Pk1 translocates to cell membranes which presumably effects cardiac target gene 
expression. 
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4 Materials and Methods 
4.1 Materials 
4.1.1 Equipment and Software 
Table 1: Overview of Equipment. 
Equipment Purpose Manufacturer 
FACSAria™ I  
Flow Cytometer 
FACS Sorting BD Biosciences 
FemtoJet Microinjection Eppendorf 
M165 Fluorescent Microscopy Leica 
MD G33 Brightfield Microscopy Leica 
SP5 Confocal Microscopy Leica 
SP8 Confocal Microscopy Leica 
ViiA™ 7 Quantitative Real-Time PCR Life Technologies 
 
Table 2: Overview of Software. 
Equipment Purpose Vendor / URL 
A Plasmid Editor (APE) Plasmid Editor 
http://biologylabs.utah.edu/jorgensen
/wayned/ape/ 
Adobe Illustrator Illustration of Data Adobe Systems, Inc. (San Jose, US) 
Adobe Photoshop Image Processing Adobe Systems, Inc. (San Jose, US) 
ClustalW2 Sequence Alignment www.ebi.ac.uk/Tools/msa/clustalw2/ 
GraphPad Prism 5 Statistical Analysis 
GraphPad Software, Inc.  
(La Jolla, US) 
ImageJ Image Processing http://imagej.nih.gov/ij/ 
MATLAB Cell Orientation 
http://de.mathworks.com/products/ 
matlab/ 
Packing Analyzer Image Analysis https://idisk-srv1.mpi-cbg.de/~eaton/ 
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Papers 3 Reference Manager http://www.papersapp.com/mac/ 
Past Rose Plots http://folk.uio.no/ohammer/past/ 
 
4.1.2 Kits 
Table 3: List of kits. 
Kits Purpose Manufacturer 
GeneJET Gel Extraction Kit PCR Purification Thermo Scientific 
mMESSAGE mMACHINE ® T7 Kit RNA Transcription Ambion 
pGEM®-T Easy Vector System Subcloning Promega 
RNeasy Mini Kit RNA Extraction Qiagen 
 
4.1.3 Chemicals and Reagents 
Unless otherwise stated chemicals, enzymes, markers, and oligonucleotides were 
purchased from Ambion, Applied Biosystems, Biorad, Biozym, Calbiochem, Life 
Technologies, New England Biolabs, Qiagen, Promega, Roche, Roth, R&D Systems, Sigma-
Aldrich, Stratagene, Thermo-Scientific, and VWR. 
 
4.1.4 Buffers and Solutions 
Buffers and solutions listed in Table 4 are indicated in bold in the following Chapters. 
Table 4: Overview of buffers and solutions. 
Name Composition 
Blocking Buffer 
PBS; 5% Normal Goat Serum; 1% DMSO; 0.1% 
Tween-20; 2 mg/mL BSA 
Tyrode’s Solution 
136 mM NaCl; 5.4 mM KCl; 1 mM MgCl2; 1.8 
mM CaCl2; 10 mM HEPES; 5 mM D(+) Glucose; 
0.3 mM Na2HPO4; pH 7.4 
Danieau’s Buffer 
17.4 mM NaCl; 0.21 mM KCl; 0.12 mM MgSO4; 
0.18 mM Ca(NO3); 1.5 mM HEPES; pH 7.6 
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E3 Medium 
5mM NaCl; 0.17 mM KCl; 0.33mM CaCl; 
0.33mM MgSO4; pH 7.4 
PEM 
0.1 M PIPES (pH 6.95); 2 mM EGTA; 1 mM 
MgSO4 
 
4.1.5 Oligonucleotides 
Oligonucleotides were purchased from BioTeZ Berlin Buch GmbH (Berlin, DE). They were 
synthesized in 10 nmol scale, dissolved in destilled water and stored as 100 mM stock and 
10 µM solutions at -20°C. 
 
4.1.5.1 Genotyping 
Table 5: List of oligos used for genotyping of mutants and CRISPants. 
Gene Oligo Sequence Size 
Fz7a 
fw 
rv 
CAAACCCGACGCCCTAC 
ATGAGGTACCGATGAAGAGG 
765 bp 
Pk1a 
fw 
rv 
GGCAGCGCTGAGCATCATAG 
GCGAATGTTGTCTGTTTTGGAGC 
462 bp 
 
4.1.5.2 sgRNA Synthesis 
Table 6: Overview of oligos for sgRNA synthesis. 
Target-Gene Sequence 
Pk1a 
GAAATTAATACGACTCACTATA GGAGCTGGAGAATCACGGTG 
GTTTTAGAGCTAGAAATAGC 
sgRNA rv 
AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGC
CTTATTTTAACTT GCTATTTCTAGCTCTAAAAC 
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4.1.5.3 Morpholino Oligonucleotides 
Table 7: Morpholino antisense oligonucleotides from GeneTools. 
Morpholino [c]E Target Sequence 5’-3’ 
MO1-dvl2 3.5 ng ATG of dvl2 TAAATTATCTTGGTCTCCGCCATGT 
MO1-fzd7a 1.5 ng 5’UTR of fz7a ATAAACCAACAAAAACCTCCTCGTC 
MO1-mylk3 3.5 ng ATG of mylk3 TACAGCGAGGTCCCCATCATGCCCT 
MO1-pk1a 1.5 ng ATG of pk1a GCCCACCGTGATTCTCCAGCTCCAT 
MO1-tnnt2 1 ng ATG of tnnt2 CATGTTTGCTCTGATCTGACACGCA 
MO1-vangl2 2 ng ATG of vangl2 GTACTGCGACTCGTTATCCATGTC  
MO2-wnt11 
1.5 ng; 
0.7 ng 
ATG of wnt11 GTTCCTGTATTCTGTCATGTCGCTC 
MO2-wnt5b 
1.5 ng; 
0.7 ng 
exon 6 splice acceptor 
of wnt5b 
TGTTTATTTCCTCACCATTCTTCCG 
 
4.1.6 Vectors 
4.1.6.1 Gateway Cloning 
Table 8: Overview of vectors utilized for generation of expression constructs. 
Gateway Cloning Vectors Description 
pDONR221 backbone for middle entry vector 
pDEST crystalline-YFP 
backbone for destination vector with YFP marker 
gene expression in the eye 
myl7 p5’E myocardial promoter 
polyA p3’E polyA tailing 
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4.1.6.2 Vectors 
Table 9: List of expression constructs. 
Expression Construct Description 
myl7:lck-eGFP 
myocardial expression of membrane tethered 
eGFP 
myl7:lifeact-RFP myocardial expression of actin-binding RFP 
 
4.1.7 Antibodies 
4.1.7.1 Primary Antibodies 
Table 10: Overview of applied primary antibodies. 
Primary Antibody 
Dilution / 
Quantity 
Origin Supplier Order No. 
Alcam a 1:25 Mouse DSHB zn-8 
DNaseI (Alexa Fluor® 488 
Conjugate) 
1:100  Life Technologies D-12371 
GFP 1:200 Rabbit Sigma-Aldrich G1544 
GFP 1:200 Rabbit Abcam ab290 
MHC 1:50 Mouse DSHB MF-20 
Myl12/9 1:100 Rabbit Abcam ab64161 
N-Cadherin 1:50 Mouse BD Biosciences 610920 
phospho-Myl9  
(phospho S20) 
1:100 Rabbit Abcam ab2480 
Pk1a 1:100 Rabbit Abcam Ab15577 
SRFa 1:100 Rabbit Abcam ab101246 
 
  
Materials and Methods 
 
75 
4.1.7.2 Secondary Antibodies 
Table 11: List of applied secondary antibodies. 
Secondary Antibody 
Dilution / 
Quantity 
Origin Supplier Order No. 
Anti-mouse IgG Alexa 
Fluor® 488 Conjugate 
1:500 Donkey Life Technologies A-21202 
Anti-mouse IgG Alexa 
Fluor® 555 Conjugate 
1:500 Goat Life Technologies A-21422 
Anti-mouse IgG Alexa 
Fluor® 633 Conjugate 
1:500 Goat Life Technologies A-21050 
Anti-rabbit IgG Alexa 
Fluor® 488 Conjugate 
1:500 Donkey Life Technologies A-21206 
Anti-rabbit IgG Alexa 
Fluor® 555 Conjugate 
1:500 Goat Life Technologies A-21428 
Anti-rabbit IgG Alexa 
Fluor® 647 Conjugate 
1:500 Goat Life Technologies A-21246 
Zenon® IgG Alexa Fluor® 
488 Conjugate 
  Life Technologies Z-25302 
Zenon® IgG Alexa Fluor® 
555 Conjugate 
  Life Technologies Z-25305 
 
4.1.8 TaqMan Probes for qPCR 
Table 12: List of TaqMan probes for qRT-PCR. 
Gene Order No. Amplicon Length Exon Boundary 
acta1b Dr03440340_m1 62 nt 1 - 2 
acta2 Dr03088509_mH 68 nt 6 - 7 
actc1b Dr03451294_s1 151 nt 8 - 8 
eef1α Dr03432748_m1 106 nt 1 - 2 
etv4 Dr03138282_m1 76 nt 1 - 2 
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fgf4 Dr03080033_m1 78 nt 1 - 2 
myl7 Dr03105697_m1 75 nt 2 - 3 
pk1a Dr03112723_m1 97 nt 3 - 4 
pk1b Dr03141824_m1 68 nt 2 - 3 
srfb Dr03106979_m1 82 nt - 
tagln2 Dr03151758_m1 102 nt 3 - 4 
 
4.1.9 Eukaryotic Cells 
Table 13: H9c2 cell line information. 
Cell Line Description Culture Medium Vendor Article Number 
H9c2 
Rat Cardiac 
Myoblast Cell 
Line 
DMEM + 2mM Glutamine 
+ 10% Fetal Bovine 
Serum (FBS) 
ATCC ATCC® CRL-1446™ 
 
4.1.10 siRNA 
Table 14: Information on fzd7a siRNA. 
Target Manufacturer Order No. Target Sequences 
fzd7a DharmaFECT 
ON-TARGETplus SMARTpool 
LOC100360552 
L-115723-00-0005 
GCUAAGACUUGCAGGACGA; 
GCCCAAAUGAAAAGGCGAA; 
GCGAGAACUUCCCGGUGCA; 
GCUAGAGUCCUAACGCAGA 
 
4.1.11 Transgenic Zebrafish Lines 
Table 15: Transgenic Zebrafish Lines 
Transgenic Zebrafish Line Function 
Tg(myl7:eGFP) Myocardial marker (cytosolic GFP) 
Tg(drl:eGFP) FHF marker 
Tg(myl7:lck-eGFP)* Myocardial expression of membraneous GFP 
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fzd7ae3 Non-Sense Mutation in Fzd7a 
vangl2m209 Non-Sense Mutation in Vangl2 
slb Non-Sense Mutation in Wnt11 
ppt Non-Sense Mutation in Wnt5b 
*provided by Alexander Meyer, MDC Berlin (previously unpublished)  
Materials and Methods 
 
78 
4.2 Methods 
4.2.1 Zebrafish Methods 
4.2.1.1 Zebrafish husbandry 
Zebrafish were bred, raised and maintained at 28°C following standard procedures according 
to the German Animal Welfare Act (Nüsslein-Volhard et al., 2003). Zebrafish strains AB, 
TüLF, wik, and TU were used for analysis of wild type phenotypes and for injection of 
constructs and CRISPR sgRNA / Cas9 protein. Embryos were kept in E3 medium (Table 4) 
with or without 1% methylene blue. At around 24 hpf embryos were treated with 0.003% PTU 
to prevent pigmentation if required (Burrill and Easter, 1994). Staging was performed as 
described previously by hours post fertilization (hpf) or by counting somites (Kimmel et al., 
2005). The experiments were declared and approved by the Landesamt für Gesundheit und 
Soziales. 
4.2.1.2 Expression Vector Generation 
Expression vectors were generated using the Gateway® cloning system (Invitrogen). In brief, 
genes of interest were amplified from genomic DNA or commercially available expression 
vectors (addgene) using specific oligonucleotides that add attB sites to the 5’ and 3’ ends of 
the sequence. The resulting product was inserted via recombination into a donor vector 
(pDONR221) containing the corresponding attP sites in the Gateway-specific BP reaction 
using BP clonase. In a subsequent LR reaction the DONR plasmid containing the gene of 
interest flanked by attL sites is recombined into a destination vector (pDEST) comprising the 
homologous attR sites. Furthermore, recombination into pDEST requires addition of a 5’ 
entry vector containing the desired promoter sequence and a 3’ entry vector containing a 
polyA sequence. Additionally, both 5’ entry and 3’ entry vectors can carry sequences for 
addition of N- or C-terminal tags. A detailed description of the Gateway® cloning system can 
be found in the manufacturer’s instructions. Vectors used for generation of expression 
constructs are listed in Table 8. Expression vectors used in this study are listed in Table 9. 
4.2.1.3 Microinjections and Morpholino Mediated Gene Knockdown 
Genetic manipulations were performed by injection of in-vitro transcribed mRNA, expression 
constructs, antisense morpholino oligonucleotides or sgRNA-Cas9 protein complexes 
(CRISPR-Cas9 mutagenesis) into Zebrafish embryos at one-cell stage. Morpholino 
antisense oligonucleotides block translation by complementary binding to mRNA. Fertilized 
eggs were mounted on 1.5% agarose moulds and injected either into the yolk (morpholino 
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knockdown) or directly into the cell (mRNA, expression constructs, sgRNA-Cas9 complexes) 
using a FemtoJet® microinjector (Eppendorf). 10 pg of expression constructs were injected 
with 25 pg of Transposase mRNA for promoter driven transient expression of specific genes. 
Morpholino oligonucleotides and expression constructs were diluted in Danieau buffer 
(Table 4). Morpholino end concentrations are indicated in Table 7. CRISPR-Cas9 
Mutagenesis is described in detail in the following paragraph. 
4.2.1.4 CRISPR-Cas9 Mutagenesis 
Targeted mutagenesis using the CRISPR-Cas9 system was performed in collaboration with 
the group of C. Mosimann (University of Zurich, Switzerland). Transient somatic and germline 
mutations were achieved by injection of sgRNA-Cas9 protein mix into cytoplasm of one-cell 
stage zebrafish embryos. Synthesis of sgRNA was performed by PCR amplification and 
subsequent in-vitro transcription. A unique oligonucleotide contained the T7 polymerase 
binding site, the sgRNA target sequence, and part of the hairpin structure important for Cas9 
binding, while a common oligonucleotide comprised the remaining sequence to generate the 
hairpin structure. The unique and common oligonucleotides were designed to overlap and 
allow to perform the subsequent PCR for the sgRNA synthesis without a template. PCR was 
performed using Phusion polymerase in HF buffer in 100 μL reaction volumes (oligos for 
amplification: Table 6). Amplification was performed on an Eppendorf Mastercycler ep 
Gradient S with the following program: 98°C – 30 s; 40 cycles of 98°C – 10 s, 60°C – 30 s, 
72°C – 15 s; 72°C 10 min; 10°C infinite. Purification of PCR products was performed using 
a PCR purification kit. In-vitro transcription was performed using the Ambion MEGAscript T7 
Kit with 300 ng purified DNA template over night at 37°C. sgRNA was purified using the 
Qiagen RNeasy Mini Kit, diluted to 600 ng / μL and stored in aliquots at -80°C. 
Cas9 protein was expressed from the plasmid pET-28b-Cas9-His (Addgene plasmid #47327; 
(Gagnon et al., 2014) by Anja Schütz from the Helmholtz Protein Sample Production Facility 
at MDC. The injection mix was adjusted for optimal KCl concentration and sgRNA / Cas9 
protein ratio using the “CrispantCal: CRISPR/Cas9 Injection Mix Calculator” 
(https://lmwebr.shinyapps.io/CRISPR_Cas9_mix_calc/). Single embryos showing mild or 
severe phenotypes were selected and analyzed to determine mutagenesis efficiency (oligos 
for genotyping: Table 5). 
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4.2.1.5 Isolation of Genomic DNA from Zebrafish Fins and Single 
Embryos 
Adult fish and 24 hpf to 72 hpf old embryos were anaesthetized in 0.016% Tricaine in E3 
medium before taking fin samples and collecting single embryos. The tissue was lysed in 50 
μL of 50 mM NaOH solution by boiling for 20 min at 95°C. The reaction was stopped by 
adding 5 μL of 1M Tris buffer (pH 8.0). Samples were used for PCR amplification and stored 
at 4°C. 
4.2.1.6 Analysis of Efficiency of Transient CRISPR/Cas9 Mutagenesis 
Genomic DNA from wild type and zebrafish showing mild or severe phenotypes was isolated 
as described in Chapter 4.2.6. A region of approx. 500 bp spanning the CRISPR / Cas9 
target sequence was amplified with specific oligonucleotides (Table 6) using Taq polymerase 
in 25 μL reaction volumes on an Eppendorf Mastercycler ep Gradient S with the following 
program: 98°C – 30 s; 35 cycles of 98°C – 10 s, 60°C – 30 s, 72°C – 15 s; 72°C 10 min; 
10°C infinite. Fragments were cloned into the pGEM T-easy vector, transformed into the E. 
coli strain DH5α and spread on ampicillin containing plates (100 µg/mL). Single colonies 
were dissolved into LB medium and 1 µL was used for colony PCR using Taq polymerase in 
25 µL. Amplification was performed with T7 fw and SP6 oligonucleotides on a Eppendorf 
Mastercycler ep Gradient S using the above mentioned program. Products were diluted 1:3 
and sent for sequencing (Source BioScience, Berlin) (oligos for genotyping: Table 5). 
Bioinformatic analysis to determine frequency and length of insertions and deletions was 
performed by Helen Lindsay (University of Zurich, Switzerland). 
4.2.1.7 Genotyping of Mutant Strains 
Genomic DNA was extracted from Zebrafish fins as described in Chapter 4.2.6. The PCR 
reaction contained 1-2 μL gDNA, 2.5 μL 10x DreamTaq Buffer, 0.5 μL dNTPs (10 mM each), 
0.25 μL fw-Primer (50 μM), 0.25 μL rv-Primer (50 μM), 2 μL MgCl2, and 0.2 μL DreamTaq 
Polymerase (Thermo Scientific) in a volume of 25 μL. Amplification was performed on an 
Eppendorf Mastercycler ep Gradient S with the following program: 98°C – 30 s; 40 cycles of 
98°C – 10 s, 60°C – 30 s, 72°C – 15 s; 72°C 10 min; 10°C infinite. PCR products were 
analyzed on an 1.5% agarose gel and diluted 1:3 and sent for sequencing (Source 
BioScience, Berlin). 
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4.2.1.8 Fluorescent-Activated Cell Sorting 
Embryos were treated with 0.25% Trypsin until homogenous cell suspension was achieved. 
Cell suspension was put through cell strainer (70 µm Nylon) and centrifuged by 200g for 20 
min at 4°C. Supernatant was removed until 1ml and 100 µl 100% FCS added to stop 
trypsinization. Cell pellet was resuspended and centrifuged at 200g for 10 min at 4°C. 
Supernatant was removed and pellet washed with 2% FCS. After centrifugation at 200g for 
10 min at 4°C, pellet was resuspended in 100 – 100 µl 1x PBS. FACS sorting was performed 
after final filtration of cell suspension. 
4.2.1.9 RNA Isolation, cDNA Synthesis and Quantitative PCR (qRT-PCR) 
Total RNA was isolated from 24 hpf, 54 hpf, 72 hpf or 120 hpf old embryos using TRIzol® 
reagent (Life Technologies). The tissue was homogenized using 23- and 27-gauge needles 
and RNA was precipitated with Chloroform/Isopropanol and GlycoBlue™ (Life 
Technologies). On-column DNaseI treatment, clean-up and concentration of RNA were 
performed according to RNeasy MicroKit (Qiagen). Reverse transcription was done using 
First-Strand cDNA Synthesis Kit (Thermo Scientific). For reverse transcription of mRNA into 
cDNA a mix of random hexamers and oligo dT primers (1:1), Reaction Buffer (5x), Ribolock 
RNase inhibitor (20 u/µl), dNTP Mix (10 mM) and M-MuLV Reverse Transcriptase (20 u/µl) 
was added to 200 – 2000 ng of RNA. The reverse transcription reaction was incubated for 5 
min at 25°C followed by 60 minutes at 37°C on an Eppendorf Mastercycler ep Gradient S. 
Quantitative RT-PCR was performed on 50 – 75 ng cDNA using FAM dye-labeled 
TaqMan MGB probes (Table 12) and Gene Expression Master Mix (Applied Biosystems) 
on a ViiA7 PCR system. The following conditions were used: annealing at 50°C for 2 min; 
denaturation at 95°C for 10 min; denaturation at 95°C for 15 s; amplification at 60°C for 1 
min. Data were analyzed using ViiA 7 RUO software (Life Technologies). Fold induction 
was determined using ΔΔCt calculation. The data were normalized to the internal 
housekeeping gene eef1a1l labeled with VIC dye. Fold induction was determined using 
ΔΔCt calculation. 
4.2.1.10 In Vivo Imaging  
Embryos were anaesthetized with 0.016% Tricaine and embedded in a ventral position in 
1% low melting agarose for immobilization in glass bottom dishes. In vivo imaging was 
performed using a Leica SP8 microscope with a 20 x (NA=0.8) water immersion objective. 
During acquisition embedded zebrafish were kept in a chamber with 28°C and covered with 
E3 medium containing 0.016% Tricaine. 
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4.2.1.11 Immunofluorescence Stainings 
Hearts were dissected in Tyrode’s solution (Table 4) with 20 mg/mL BSA and subsequently 
fixed in 4% FA in PEM (Table 4) or Glyo-Fixx™ for 20 min (Thermo Scientific). Subsequently, 
hearts were washed and stored up to one week in PBST (0.1% Tween-20). For ROCK-
inhibition dissected hearts were treated for 1 h with 200 µM Y-27632. Treated and untreated 
hearts were incubated in blocking solution (Table 4) for 1 h. Hearts were incubated with 
primary antibodies (Table 10) diluted in blocking buffer over night at 4°C. After three washing 
steps in blocking buffer á 30 min hearts were incubated with Alexa-conjugated secondary 
antibodies (Table 11) diluted in blocking buffer for 2 h at RT. Finally, hearts were washed 
over night in PBS and 0.1% Tween-20 before mounting in ProLong Antifade with DAPI (Life 
Technologies). 
4.2.1.12 Confocal Microscopy 
Immunostainings of fixed hearts were analyzed using the Leica SP5 or SP8 confocal laser 
scanning microscope with 63x (NA=1.4) oil or 63x (NA=1.3) glycerol objective. Images were 
analyzed using ImageJ (NIH), Fiji (http://fiji.sc/Fiji) and Packing Analyzer (Aigouy et al., 
2010). Statistical analysis was performed using Prism (GraphPad) (Table 1 & 2). 
4.2.2 Cell Culture Methods 
4.2.2.1 Culturing of H9C2 Rat Myoblast Cell Line 
H9c2 cells were grown in DMEM medium (Gibco) and subcultured twice a week. Cells that 
reached 70% confluency were washed in ice-cold PBS and incubated with 1x Trypsin-EDTA 
for 2-10 min at 37°C. Trypsinization was stopped after detachment of cells with FBS 
containing DMEM. A defined volume of cell suspension was transferred into a new cell 
culture flask with fresh DMEM. Cell counting was performed with a ScepterTM 2.0 pipette 
with 60 µM tips. Only cells of 9-21 µM size were counted. 
4.2.2.2 Immunofluorescence Microscopy of H9c2 
Cells were plated and cultured on sterile coverglasses in 24-well plates and fixed at approx. 
70% confluency in 4% PFA / 4% Sucrose in PBS for 20 min. Two washing steps with PBS 
were performed after every subsequent treatment if not stated otherwise. PFA-reaction was 
quenched with 50 mM Ammoniumchloride for 10 min. Subsequently, cells were 
permeabilized with 0.2% Triton for 5 min and washed with 0.2% Gelatine for 5 min. Unspecific 
sites were blocked with 1% Gelatine for 1 h. Cells were incubated with primary antibodies 
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(Table 10) diluted in 1% Gelatine for 1 h in a wet chamber. Cells were washed twice in 1% 
Gelatine before treatment with secondary antibody in 1% Gelatine for 30-45 min (Table 11). 
Nuclei were stained with 5µM Hoechst in PBS for 10 min. Final fixation was performed with 
4% PFA / 4% Sucrose in PBS for 5 min and subsequent treatment with NH4Cl for 5 min. Final 
washing was performed with 1% Gelatine, 0.2% Gelatine and PBS for 5 min each. 
Coverslides were mounted on 4 µL of ProLong Antifade with DAPI (Life Technologies) and 
stored at 4°C. 
4.2.2.3 siRNA Transfection of H9c2 
H9c2 cells (Table 13) were seeded onto a 24-well plate, pre-coated with poly-D-Lysine, at 
3x104 cells per well and cultured for 24 hours. The transfection has been achieved using 
DharmaFECT TM siRNA Transfection Reagent (GE Healthcare Dharmacon) according to 
manufacturer’s instructions. Briefly, 100 nM ON-TARGETplus SMARTpool Fzd7a siRNA 
(GE Healthcare Dharmacon) was added to serum-free DMEM and then mixed with 
DharmaFECTTM (1 µl per well) (Table 14). After incubation over 30 min at RT the 
DharmaFECTTM / siRNA mixture was added to the cells. 24 hours after transfection, cells 
were harvested. 
4.2.3 Statistics 
Statistical analysis was performed using GraphPad Prism5 (Table 2). Unpaired t-test or one-
way ANOVA with Bonferonni Multiple Comparison were applied. Significant differences are 
indicated as P ≤ 0.05 = *, P ≤ 0.01 = **, P ≤ 0.001 = ***. For transitory states boxplots with 
minimum to maximum value whiskers and median are plotted. Otherwise, data are plotted 
as mean plus standard error of mean (SEM). Rayleigh’s R values were determined using 
Past software (Table 2). 
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5 Supplement 
 
 
 
Figure 37: CRISPR-mediated mutagenesis of the pk1a locus with information on phenotype and indel 
frequency (Lindsay et al., 2016).  
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7 Appendix 
Abbreviations 
µg Microgram 
µL Microliter 
µmol Micromole 
ALPM Anterior lateral plate mesoderm 
bp Base pair(s) 
BSA Bovine serum albumin 
cDNA Complementary DNA 
CE Convergent extension 
CHD Congenital heart defect 
Ct Cycle threshold 
DMEM Dulbecco’s modified eagle medium 
DMSO Dimethylsulfoxide 
DNA 2-deoxyribonucleic acid 
DNase Deoxyribonuclease 
dNTP 2’-deoxynucleoside 5’-triphosphate 
dpf Days post fertilization 
EDTA Ethylenediaminetetraacetic acid 
FA Formaldehyde 
F-Actin Filamentous Actin 
FCS Fetal calf serum 
FHF First heart field, primary heart field 
fw Forward 
G-Actin Globular Actin 
h Hour(s) 
hpf Hour(s) post fertilization 
kDa Kilo-Dalton 
l Liter 
MHC Myosin heavy chain 
MI Myocardial infarction 
min Minute 
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MLC Myosin light chain 
mRNA Messenger RNA 
NCBI National centre for Biotechnology information 
ng Nanogram 
OD Optical density 
PAM Protospacer adjacent motif 
PBS Phosphate buffered saline 
PCP Planar cell polarity 
PCR Polymerase chain reaction 
PFA Paraformaldehyde 
pMRLC Phosphorylated Myosin Regulatory Light Chain 
PTU 1-Phenyl-2-thiourea 
qRT-PCR Quantitative Real-Time-PCR 
RNA Ribonucleic acid 
RNase Ribonuclease 
rpm Revolutions per minute 
RT Room temperature 
rv Reverse 
sec Second 
SHF Second heart field 
SRF Serum response factor 
TAE Tris-acetate-EDTA 
TE Tris-EDTA 
YSL Yolk syncytial layer 
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